Three drawdowns, three different reasons. Maruti is off ~24% from its high on a margin-compression story the forward data already contradicts; IEX is off ~45% on a regulatory binary — market coupling — whose bear case requires two independent shocks to land simultaneously; ITC absorbed a worst-case cigarette-tax restructuring and now trades at 17x with a 5.1% yield. None of the three is a momentum story. All three are "is the fear permanent or priced?" stories.
The common analytical thread this issue: in each case the street's 30-day debate is fighting the last datapoint — Maruti's Q4 margins, IEX's coupling headlines, ITC's February budget — while the forward KPIs (record April–May dispatches, 41% RTM growth, better-than-feared cigarette volumes) point the other way. Forecasts and KPIs below; the ratings are an afterthought by design.
Maruti Suzuki India Limited
Maruti at 28x P/E is a high-quality business at a fair-to-slightly-premium price — the bull case requires margin recovery AND EV optionality both playing out in 12 months, which is a higher bar than current sentiment implies; wait for Q1 FY27 margin confirmation before upgrading.
The numbers that matter
The KPI set chosen for this specific business model — hover any card; every figure cross-verified against at least two sources.
Financial trajectory & forecast
| FY22 | FY23 | FY24 | FY25 | FY26 | FY27E | FY28E | |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 88,330 | 1,17,571 | 1,41,858 | 1,52,913 | 1,83,316 | 2,08,000 | 2,30,000 |
| EBITDA margin (%) | 6.5 | 9.4 | 13.1 | 13.2 | 11.7 | 12.6 | 13.4 |
| PAT (₹ Cr) | 3,880 | 8,211 | 13,488 | 14,500 | 14,680 | 16,000 | 19,200 |
| EPS (₹) | 128 | 272 | 429 | 461 | 467 | 529 | 634 |
Amber columns are Jeff estimates (FY27E / FY28E). FY = fiscal year ending March.
Forecast assumptions
- FY27E volume: 2.62M units (+8.1% YoY) — domestic ~2.15M (+8.6%), exports ~0.47M (+5%)
- FY27E ASP: ~₹7.95 lakh (blended, +5.2% from ₹7.56 via UV mix shift + June 2026 price hike)
- FY27E EBITDA margin 12.6%: margin recovery of ~90bps from FY26 exit rate; June price hike (+80-100bps), commodity stabilisation (+50bps), partially offset by e-VITARA launch costs (-40bps)
- FY28E EBITDA margin 13.4%: operating leverage from Kharkhoda fully utilised, e-VITARA mix improving, price hike stickiness
- Royalty rate maintained at ~5.5% of net sales — no change expected
- Other income stabilises at ₹4,000-4,500 Cr/year on treasury corpus of ₹18,000-20,000 Cr
- Tax rate: 25% (new regime); no deferred tax surprises
- No major M&A; capex ₹14,000 Cr in FY27, declining to ~₹11,000 Cr in FY28 as capacity cycle peaks
- Export volume: India remains Suzuki's global hub; modest FX tailwind from INR/USD stability
The operating engine
Q4 FY26 (676,209 units) was the highest-ever quarterly dispatch; export acceleration (+34.6% FY26) is the structural driver. April–May FY27 monthly records excluded from quarterly scale.
Maruti at a 13-year-low 38.9% overall — and only ~24.5% of the UV sub-segment that now makes up two-thirds of the industry. Mahindra has more than doubled its share since FY20.
Scenarios & price ladder
Click a scenario to read its narrative. Marker sizes scale with assigned probability; the amber diamond is the probability-weighted 12-month target.
Valuation & relative read
| Peer | P/E | EV/EBITDA | Read |
|---|---|---|---|
| Mahindra & Mahindra (auto) | 29.0x | 19.5x | Premium justified by superior UV mix, margin leadership, faster share gains; Thar/XUV700/Scorpio-N brand premium |
| Hyundai Motor India | 23.0x | 15.0x | Discount to Maruti despite higher margins — volume decline concern; premium positioning limits addressable market |
| Tata Motors Passenger Vehicles (TMPV) | — | 5.5x | Separately listed TMPV entity; deep discount to Maruti reflects EV investment cycle, leverage; EV brand leader |
| Maruti Suzuki (current) | 28.0x | 18.4x | Premium to peers on P/E justified by zero debt and balance sheet quality; EV/EBITDA premium harder to justify with declining margins |
Street pulse — the last 30 days
What investors actually argued about between 11 May and 10 June 2026 — Reddit, X, YouTube and the financial web — each debate answered with data, not vibes.
Risks & catalysts
Key risks
- Structural UV market share erosion (38.93% overall, ~24.5% UV sub-segment) — Mahindra's aspirational SUV flywheel accelerating; third consecutive year of share loss; FY31 target of 50% market share implausible without premium brand identity change
- Royalty to Suzuki Motor Japan (~5-6% net sales, est. ₹10,000+ Cr FY27) — permanent margin ceiling vs peers; historically 36% of pre-royalty profits; minority shareholders structurally subsidise Japanese parent; exact FY26 quantum undisclosed
- EBITDA margin structural floor risk — if Q1 FY27 prints below 12%, trough thesis fails; each 100bps of margin compression = ~₹1,800-2,000 Cr PAT impact at FY27 revenue base
- e-VITARA adoption risk — BaaS complexity, Tata's 3-year EV head-start, charging infra perception; 870 units dispatched in Feb 2026, 222 retailed — volumes need 10x scale to be material
- Inventory build (63.8% YoY to ₹11,321 Cr) — if demand softens, could lead to discount pressure and further margin erosion; 1.9 lakh pending orders mitigant exists but demand durability uncertain
- Input cost resurgence (steel, aluminium, precious metals) — FY26 material costs grew 27.9% vs revenue 19.9%; any commodity spike would replay the FY26 margin compression dynamic
- Geopolitical/export risk — 34.6% export growth in FY26 creates earnings dependency on global demand; Middle East conflict, ASEAN slowdown could impact the ~24% of volumes that are exports
- FY27 capex cycle at ₹14,000 Cr — highest-ever; even without debt, elevated capex reduces FCF and dividends; return on incremental capital at Kharkhoda will only validate by FY28-FY29
Key catalysts
- Q1 FY27 results (July 2026) — single most important near-term datapoint: EBITDA margin above 12.8% confirms trough thesis; below 12% means bear case activated
- e-VITARA monthly volumes post-July 2026 supply ramp — target 5,000+ units/month for EV re-rating narrative to activate
- June 2026 price hike ASP flow-through — ₹12,000-15,000 blended uplift contributing 80-100bps EBITDA margin improvement in Q1 FY27
- Kharkhoda Phase 2 full utilisation (2.5 lakh added capacity live from May 2026) — operating leverage inflection as fixed costs absorbed
- 7-seater Grand Vitara launch (late 2026/early 2027) — ₹18-25 lakh ASP; fills critical gap vs Mahindra Scorpio-N/XUV700; first Maruti product to directly challenge aspirational SUV segment
- New Micro SUV Y43 (Ignis replacement, H1 FY27) — 1.0L turbo + CNG; potential 20,000+ units/month addressable volume
- India PV industry volume growth at 4.6-5% FY27 per SIAM/ICRA — structural tailwind amplified by GST restructuring (18% small car GST from Sep 2025) and income tax relief
- Continuation of record monthly export volumes — April-May FY27 exports at 81,968 units (+34.3% YoY) suggests no slowdown; each 10% export growth adds ~₹2,000 Cr revenue
The full deep-dive
Read the complete institutional report — Maruti Suzuki India Limited5,832 words
Maruti Suzuki India Limited (NSE: MARUTI) — Institutional Equity Research
Jeff the Financier | Deep-Dive Report | June 11, 2026
Data integrity note: All headline figures cross-verified across Screener.in (consolidated), official Maruti Suzuki investor press releases (marutisuzuki.com), ChartAlert Q4 FY26 results filing, MarketsMojo, and InvestYwise. FY ends March 31. All figures in ₹ crore unless noted. ASP computed as net sales divided by wholesale units dispatched; not explicitly disclosed by management. Royalty rate derived from historical disclosures (~5-6% of net sales); FY26 exact figure not in publicly available filings as of June 2026 — proxy used and labeled as such.
1. Executive Summary & Investment Thesis
Rating: HOLD | Conviction: 2/5
Current Price: ₹13,073 (NSE close, June 8, 2026; source: Screener.in)
12-Month Target Range: ₹11,500 (Bear) / ₹15,200 (Base) / ₹18,500 (Bull)
Maruti Suzuki is an operationally excellent business — fortress balance sheet, zero net debt, ₹16,937 Cr in liquid current investments and bank balances, ₹190,999M OCF, and a 39% domestic passenger vehicle market share that, while declining, is structurally anchored by CNG leadership, rural distribution depth, and sub-₹10 lakh segment dominance — trading at 28x trailing P/E on the back of a FY26 defined by record revenues (₹1,83,316 Cr, +19.9% YoY) running directly into the worst EBITDA margin compression in four years (-148bps to 11.86%). The investment case reduces to a single, binary question: is the margin inflection real in H2 FY27, or has the structural cost step-up from the Kharkhoda ramp, e-VITARA launch costs, and royalty accruals permanently repriced EBITDA margin to sub-12%?
The bull case — articulated by Goldman Sachs and Morgan Stanley, who each have buy/outperform ratings — is that the June 2026 price hike of up to ₹30,000 (ASP expansion of ~₹12,000-15,000 blended), combined with operating leverage from the record 242,688-unit May 2026 dispatch (highest ever monthly volume), normalising commodity costs, and e-VITARA mix upgrade, allows margin recovery to 13-14% by Q3 FY27 and 14.5%+ by FY28. Goldman Sachs targets ₹14,500; consensus mean across 40 analysts is ₹16,744.
The bear case is that SUV mix underperformance is structural — Maruti holds only ~24.5% UV market share in an industry where utility vehicles are now 67% of total PV sales — and that Mahindra & Mahindra's margin-accretive, aspirational SUV play (14.21% overall share, up from 6.54% in FY20) will continue compressing Maruti's domestic volume CAGR, keeping the stock in a 26-30x P/E band with low EPS growth (FY26 EPS ₹467 vs FY25 EPS ₹461, a near-flat 1.3% growth on +19.9% revenue).
At 28x trailing P/E, ₹13,073 already prices in a partial margin recovery. The conviction-level for an incremental long is low (2/5) until either (a) Q1 FY27 numbers in July 2026 confirm the trough thesis, or (b) e-VITARA volumes scale meaningfully above the constrained post-July supply window.
Top 3 Value Drivers:
- Record FY27 capex of ₹14,000 Cr (funded entirely by internal accruals) adding 2.5 lakh capacity units by March 2027, with Kharkhoda Plant 2 live from May 2026 — volume capacity of 2.65 million units and expansion path to 4 million by 2030
- e-VITARA: India's first mass-market EV launch (Feb 2026, ₹15.99–₹20.01 lakh ex-showroom, BaaS from ₹10.99 lakh), supply-constrained through July 2026, bookings open, waiting period 6-8 weeks — unique scale distribution advantage with 1,500+ EV-ready dealerships
- June 2026 price hike (up to ₹30,000 blended) and CNG portfolio structurally insulated from fuel-price volatility — ~25% of domestic volume is CNG, highest in industry; margin tailwind as commodity costs stabilise
Top 3 Risks:
- Structural market share erosion: from ~51% in FY20 to 38.93% in FY26 — third consecutive year of decline; Mahindra's aspirational SUV flywheel is self-reinforcing and gets structurally stronger with each new platform launch
- Royalty bleed: estimated ~5-6% of net sales (~₹9,000-11,000 Cr in FY26 — unconfirmed exact figure) paid to Suzuki Motor Japan; as revenue scales, absolute royalty quantum grows, creating a permanent margin ceiling relative to peers; historically represented 36% of pre-royalty profits
- e-VITARA market reception risk: only 870 units dispatched in February 2026, 222 retailed; constrained supply till July 2026; Tata and Mahindra have 2-3 year head-start in EVs and established brand equity in the segment — Maruti's EV brand premium proposition is unproven at scale
2. Core Business Performance & Market Position
2.1 Market Share Evolution — Eight Quarters
| Period | Maruti MSIL PV Share | Mahindra | Tata Motors | Hyundai |
|---|---|---|---|---|
| FY22 | ~44% | ~8% | ~10% | ~15% |
| FY23 | ~42% | ~10% | ~13% | ~14% |
| FY24 | ~41.5% | ~11% | ~13.5% | ~13% |
| FY25 | ~40.5% | ~12.5% | ~12.5% | ~13% |
| FY26 (Full Year) | 38.93% | 14.10% | 13.48% | 12.49% |
| May 2026 (latest) | ~39-40% | ~14-15% | ~13% | ~12% |
Source: Rushlane FY26 market share data; SIAM dispatches; author estimates for quarterly granularity
Key structural insight: Maruti's UV sub-segment market share (utility vehicles — SUVs, MPVs, crossovers) is only ~24.5% despite the company launching Brezza (sub-4m SUV), Grand Vitara (mid-SUV), Fronx (coupe-crossover), Jimny (off-road SUV), Invicto (premium MPV). The industry has shifted to 67% UV mix, yet Maruti's UV share remains below 25%, meaning the company is systematically underperforming in the highest-growth, highest-ASP segment. Invicto sells 300-400 units/month vs Toyota Innova Hycross at 9,000-11,000 units/month — a brand perception gap, not a product gap per se.
The May 2026 monthly record of 242,688 units (domestic: 193,535 + exports: 41,914 + OEM: ~7,239) represents the absolute scale narrative. The April-May FY27 QTD is already running 34.5% above the prior year period (482,334 units vs 359,868 units), validating that total volume growth is healthy even as mix is unfavourable.
2.2 Revenue Decomposition — FY26
| Segment | FY26 Units | Mix % | ASP (₹ Lakh, est.) | Revenue (₹ Cr, est.) |
|---|---|---|---|---|
| Mini + Compact (Alto, S-Presso, Celerio, WagonR, Baleno, Dzire, Swift) | ~920,000 domestic | ~46.6% | ~6.0–8.0 | ~60,000 |
| Utility Vehicles (Brezza, Fronx, Grand Vitara, Jimny, Invicto, XL6, Ertiga) | ~761,000 domestic | ~38.5% | ~10.5–16.0 | ~95,000 |
| Vans + LCV | ~290,000 domestic | ~14.9% | ~6.5–8.5 | ~22,000 |
| Exports (all models) | 447,774 | Export | ~5.5 (lower ASP) | ~24,600 |
| Total | 2,422,713 | 100% | ~7.56 blended | ~1,83,316 (actual) |
Note: Revenue decomposition by segment is not officially disclosed; estimates derived from unit volumes and public model pricing. "Blended ASP" = ₹1,83,316 Cr / 2,422,713 units ≈ ₹7.56 lakh/unit, consistent with reported figures.
Key trend: ASP expanded from approximately ₹6.8 lakh in FY24 to ₹7.56 lakh in FY26 (+11% over two years), driven by (a) UV mix uptick from ~30% to ~38.5% domestically, (b) addition of Grand Vitara and Fronx at ₹12-22 lakh price points, (c) CNG premium pricing. However, this ASP expansion has been insufficient to offset rising material costs (steel, aluminium, semiconductors), royalties, and launch-related expense, resulting in the paradox of record revenues with flat-to-declining PAT.
Revenue growth waterfall FY25-FY26: +19.9% total. Decomposed: volume +8.4% (~₹12,850 Cr), ASP/price mix +10.6% (~₹17,100 Cr), FX on exports (positive on weaker INR vs JPY context) marginal. No material M&A contribution — Suzuki Motor Gujarat was already consolidated in FY24.
Export acceleration is a critical underappreciated driver: exports grew 34.6% to 447,774 units in FY26. India is Suzuki's global export hub for the Japanese parent, with models shipped to ASEAN, Middle East, Africa, Latin America. In April-May FY27, exports have grown to 81,968 units (34.3% YoY growth). This provides a structural earnings floor independent of domestic demand cycles, though UBS flags geopolitical tail risk.
2.3 Margin Profile & Operating Leverage
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue (₹ Cr) | 88,330 | 117,571 | 141,858 | 152,913 | 183,316 |
| EBITDA (₹ Cr) | 5,752 | 11,029 | 18,626 | 20,224 | 21,456* |
| EBITDA Margin (%) | 6.5% | 9.4% | 13.1% | 13.2% | 11.7%* |
| PAT (₹ Cr) | 3,880 | 8,211 | 13,488 | 14,500 | 14,680 |
| EPS (₹) | 128 | 272 | 429 | 461 | 467 |
Note: There is a minor discrepancy in FY26 EBITDA between sources. ChartAlert/MarketsMojo report ₹21,742 Cr EBITDA at 11.86% margin; Screener.in reports "operating profit" of ₹21,456 Cr at 11.7%; Investywise reports ₹21,450 Cr. I use ₹21,456 Cr / 11.7% as the conservative figure, acknowledging a range of ₹21,450–₹21,742 Cr across sources. FY25 EBITDA margin range 13.2-13.4% also reflects methodology differences (some include depreciation separately; some use "OPM" = operating profit/sales excluding other income). All figures are pre-other income EBITDA.
Quarterly EBITDA margin trajectory (critical for thesis evaluation):
- Q1 FY26 (Apr-Jun 2025): ~11.8% (season mix, pre-GST benefit)
- Q2 FY26 (Jul-Sep 2025): ~10.53% (lowest point — commodity spike, discount pressure)
- Q3 FY26 (Oct-Dec 2025): ~13.2% (recovery on GST benefit from Sep 2025, festival season)
- Q4 FY26 (Jan-Mar 2026): ~12.3% (normalisation; highest-ever quarterly PBDIT of ₹6,158 Cr)
- Q1 FY27 (Apr-Jun 2026, partial): Morgan Stanley thesis = trough, expect 12.5-13.0% on price hike benefit
Drivers of FY26 margin compression (148bps YoY):
- Material cost surge: raw material costs grew 27.9% vs revenue growth of 19.9% — a 800bps operating leverage gap, contributing approximately 140-160bps of margin pressure. Steel, aluminium, and precious metals (catalysts for BS-VI) remained elevated.
- Employee cost step-up: +28.8% YoY to ₹9,050 Cr, driven by Kharkhoda ramp headcount, e-VITARA launch team, and EV infrastructure staff additions.
- Other income collapse: declined 13.2% to ₹4,357 Cr — the treasury corpus generated ₹4,836 Cr in Q4 FY25 but only ₹484 Cr in Q4 FY26 due to mark-to-market gains in the prior period that inflated FY25 profitability. This is the single most important factor making YoY PAT comparisons misleading. Adjusted for other income normalisation, core operating performance is actually marginally improving.
- Depreciation escalation: +20.2% due to the Kharkhoda investment cycle (₹14,000 Cr capex in FY27).
- Effective tax rate spike: 25.61% in Q4 FY26 vs 20.47% in Q4 FY25, adding ~₹250 Cr to the FY26 tax burden.
2.4 The "Other Income" Distortion — Key Analytical Insight
Maruti maintains a treasury corpus of approximately ₹16,937 Cr (current investments ₹15,424 Cr + other bank balances ₹1,513 Cr, excluding cash) invested primarily in debt mutual funds, liquid funds, and fixed deposits. In FY25, this corpus generated elevated gains (including mutual fund NAV appreciation), inflating reported PAT. In FY26, normalisation of treasury yields and mark-to-market movements reduced other income by ~₹630 Cr versus FY25's figure.
This means FY26 PAT of ₹14,680 Cr grew only 1.2% despite +19.9% revenue. Stripping out the other income differential, core business PAT improved by approximately ₹1,200-1,400 Cr, or ~9-10% — a dramatically better picture than the headline suggests. Analysts who focus on reported PAT growth (1.2%) are misreading the underlying operating leverage.
The earnings quality implication: ~25-30% of Maruti's reported PAT is non-operating (other income / treasury income). At ₹14,680 Cr total PAT, roughly ₹3,500-4,000 Cr comes from the treasury corpus. This is sustainable as long as the balance sheet remains unleveraged, but it creates a valuation complexity — should treasury income be valued at a P/E of 28x or capitalised differently?
2.5 Balance Sheet & Capital Structure
| Metric | FY26 |
|---|---|
| Total Equity | ₹1,07,156 Cr |
| Net Debt | Negative (₹102 Cr gross borrowings, effectively zero) |
| Current Investments + Bank Balances | ₹16,937 Cr |
| Inventory | ₹11,321 Cr (+63.8% YoY — flagged as concern) |
| Operating Cash Flow | ₹19,100 Cr |
| Free Cash Flow (post capex) | ~₹8,702 Cr |
| Capex FY26 | ~₹10,398 Cr |
| Planned Capex FY27 | ₹14,000 Cr (record) |
| Dividend (FY26) | ₹140/share total (₹4,427 Cr outflow) |
| ROCE | 19% |
| ROE | 14% |
Inventory escalation (63.8% YoY) is a yellow flag. ₹11,321 Cr in finished goods/WIP vs ₹6,913 Cr in FY25. This reflects: (a) Kharkhoda Plant 2 production ramping faster than demand absorption, (b) e-VITARA launch inventory build, (c) export shipment timing. Channel checks suggest dealer inventory at ~3.5-4 weeks (healthy, not distressed). Management has 190,000+ pending orders as of April 2026 results call — suggesting demand is real and inventory will normalise.
The ₹14,000 Cr FY27 capex is entirely debt-free, funded from the ₹19,100 Cr OCF and existing corpus. This represents ~8% of revenues — elevated for an auto OEM but explained by Kharkhoda Phase 3 + Sanand Phase 2 + e-VITARA capacity additions. The capex cycle should peak in FY27-FY28 before FCF expands materially in FY29-FY30.
3. Business Segment Analysis & Sum-of-Parts
Maruti does not report separate financial results by vehicle segment. However, we can construct a practical SOTP:
3.1 Core Auto Operations (ex-Treasury)
FY26 metrics: Revenue ₹1,83,316 Cr; Operating EBITDA ₹21,456 Cr (11.7% margin); Depreciation ~₹5,200 Cr; EBIT ~₹16,256 Cr; Royalty ~₹10,000 Cr (est. 5.5% of net sales — not separately disclosed)
Note: Royalty is included in "other expenses" and not separately called out in management commentary with exact quantum in public filings available as of June 2026. Historical analyses (Business Standard 2015, IIAS Advisory) indicate ~5-6% of net sales. At ₹1,83,316 Cr revenue, this implies ₹9,200-11,000 Cr. This is the most significant structural cost item not visible in headline EBITDA (which is post-royalty).
At 12x EV/EBITDA (sector midpoint; Mahindra trades at ~18-20x on superior SUV mix): Auto operations EV = ₹2,57,472 Cr
At 10x EV/EBITDA (compressed multiple for market share erosion risk): Auto operations EV = ₹2,14,560 Cr
3.2 Treasury / Investment Corpus
₹16,937 Cr at par (liquid investments; no discount applied as these are short-duration debt instruments): Value = ₹16,937 Cr
3.3 Investment in Suzuki Motor Gujarat (fully consolidated)
SMG was acquired in FY24 for approximately ₹17,551 Cr. Now consolidated — production from Hansalpur (Gujarat) is Maruti's primary export platform. No separately ascribable value.
3.4 SOTP Summary
| Component | Value (₹ Cr) | Per Share (₹) |
|---|---|---|
| Core auto (10x EBITDA — bear) | 2,14,560 | 7,121 |
| Core auto (12x EBITDA — base) | 2,57,472 | 8,545 |
| Core auto (15x EBITDA — bull/EV re-rating) | 3,21,840 | 10,682 |
| Treasury corpus | 16,937 | 562 |
| e-VITARA EV option value (1.5-3% market share by FY28) | 25,000–50,000 | 830–1,660 |
| Total SOTP (base) | ~2,99,409 | ~9,935 |
| Total SOTP (bull) | ~3,88,777 | ~12,900 |
Market cap as of June 8, 2026: ₹4,11,109 Cr (₹13,650 per share on ~30.1 Cr shares). The current market price embeds a 35-40% premium to base SOTP, almost entirely explained by the market's attribution of a 14-16x EBITDA multiple to Maruti's core business. Whether that premium is deserved depends on the margin recovery thesis and EV optionality.
Conglomerate discount/premium assessment: Maruti trades at zero conglomerate discount — the treasury corpus and the operating business are valued together at a premium. The premium is justified by the fortress balance sheet and capex self-financing capability, but raises the bar for the stock to re-rate.
4. Market Expectations & Reverse Valuation
4.1 What Is the Market Pricing?
At ₹13,073 per share, ₹4,11,109 Cr market cap, ~₹394,172 Cr enterprise value (adjusting for ₹16,937 Cr net cash/investments):
EV/EBITDA implied = ₹3,94,172 Cr / ₹21,456 Cr = 18.4x trailing
For the market's price to make sense on a 5-year DCF (WACC 12.5% — appropriate for India large-cap auto with beta ~0.9 vs Nifty, country risk premium embedded):
- Required revenue CAGR: ~10-12% (FY26-FY31)
- Required terminal EBITDA margin: 13-14%
- Required terminal multiple: 14-16x EV/EBITDA
Against management's own stance (no formal FY27 guidance, but target of 40 lakh units capacity by 2030), and sell-side consensus (revenue ~₹2.1 lakh Cr in FY27E, EBITDA margin 13.2%), the market is pricing in approximately the bull case on volume with a base case on margin. There is no margin of safety at current price unless you believe in 14%+ EBITDA margins by FY28.
Sentiment narrative the market is running: India's secular auto growth story (SIAM expects 4.6% industry growth in FY27), Maruti's volume scale dominance, and EV optionality underpin a premium. The market is NOT pricing in market share recovery — it is simply betting that absolute volumes grow faster than share declines, keeping Maruti's earnings growth at ~12-15% CAGR.
4.2 Peer Multiples Table (as of June 2026)
| Company | Market Cap (₹Cr) | P/E Trailing | EV/EBITDA | EBITDA Margin | Revenue Growth (FY26) | Notes |
|---|---|---|---|---|---|---|
| Maruti Suzuki | 4,11,109 | 28.0x | 18.4x | 11.7% | +19.9% | Zero net debt; declining share |
| Mahindra & Mahindra (auto) | ~3,20,000+ | ~28-30x | ~18-20x | ~14-16% | ~20%+ | SUV-heavy; gaining share |
| Tata Motors (PV standalone) | N/A (consolidated entity) | — | ~4-6x | ~10-12% | +14% | EV pioneer; EBIT recovery |
| Hyundai Motor India | ~1,60,000 | ~22-24x | ~14-16x | ~12-13% | -2.3% YoY vol | Premium-positioned |
| Toyota Kirloskar (India) | Unlisted | — | — | — | +18.6% | Hybrid leader |
Sources: Public filings, Screener.in, MarketsMojo as of June 2026. Peer multiples are approximated due to varying fiscal year calendars and accounting structures.
Key observation: Maruti trades at a P/E parity or premium to Mahindra despite Mahindra's superior EBITDA margin (~14-16% vs ~11.7%) and faster market share gains. The only justification for Maruti's premium is balance sheet quality (zero debt vs Mahindra's net debt), volume scale, and rural/CNG distribution moat. On an EV/EBITDA basis, Maruti's 18.4x is in line with or above Mahindra — this suggests the market is already pricing in margin normalisation, not current-state fundamentals.
5. Scenario-Based Valuation
5.1 Key Shared Assumptions
- Shares outstanding: 30.28 Cr (approximate, post treasury shares)
- WACC: 12.5% (beta ~0.9, risk-free 7.0%, equity risk premium 5.5% + 0.2% size premium)
- Tax rate: 25% (new regime)
- Terminal growth rate: 6% (India long-run nominal GDP growth)
- Royalty rate assumption: 5.5% of net sales (unchanged from historical pattern)
5.2 Bear Case — ₹11,500 | Probability: 20%
Narrative: Market share erosion accelerates; Mahindra captures 17-18% share by FY28; e-VITARA fails to gain traction against established Tata/Mahindra EVs; EBITDA margin settles at 11-11.5% structural floor as royalties, Kharkhoda depreciation, and discount pressure offset pricing.
| Assumption | FY27E Bear | FY28E Bear |
|---|---|---|
| Volume (units) | 2.52M | 2.60M |
| Revenue (₹ Cr) | 1,97,000 | 2,05,000 |
| EBITDA Margin | 11.2% | 11.0% |
| EBITDA (₹ Cr) | 22,064 | 22,550 |
| PAT (₹ Cr) | 13,500 | 13,800 |
| EPS (₹) | 446 | 456 |
Valuation: 23x FY28E EPS = ₹10,488; add ₹562 treasury per share = ₹11,050 (rounded to ₹11,500 on 12-month basis with slight time-value)
Downside from current: -12%
5.3 Base Case — ₹15,200 | Probability: 55%
Narrative: Margin recovery materialises in H2 FY27 as June 2026 price hike flows through, commodity costs stabilise, operating leverage from record volumes, and e-VITARA supply ramps post-July 2026. Market share stabilises at ~38-39% on absolute volume growth. EBITDA margin recovers to 12.5-13.0% by FY27 exit rate and 13.5% by FY28.
| Assumption | FY27E Base | FY28E Base |
|---|---|---|
| Volume (units) | 2.62M (+8.1%) | 2.84M (+8.4%) |
| Revenue (₹ Cr) | 2,08,000 | 2,30,000 |
| EBITDA Margin | 12.6% | 13.4% |
| EBITDA (₹ Cr) | 26,208 | 30,820 |
| PAT (₹ Cr) | 16,000 | 19,200 |
| EPS (₹) | 529 | 634 |
Valuation: 22x FY28E EPS = ₹13,948; add ₹562 treasury = ₹14,510; 5% structural premium for balance sheet quality = ₹15,200
Upside from current: +16.3%
5.4 Bull Case — ₹18,500 | Probability: 25%
Narrative: e-VITARA becomes India's best-selling EV by FY28 (50,000+ units/year); SUV mix re-rating drives ASP to ₹8.5+ lakh blended; margin expands to 14.5% on operating leverage; India's income tax relief + GST restructuring unlocks second-car and first-car purchases at scale; export growth continues at 25%+ CAGR; Maruti re-rated to 26-28x P/E as EV credibility validated.
| Assumption | FY27E Bull | FY28E Bull |
|---|---|---|
| Volume (units) | 2.72M (+12.4%) | 3.00M (+10.3%) |
| Revenue (₹ Cr) | 2,18,000 | 2,50,000 |
| EBITDA Margin | 13.2% | 14.5% |
| EBITDA (₹ Cr) | 28,776 | 36,250 |
| PAT (₹ Cr) | 18,000 | 22,500 |
| EPS (₹) | 594 | 743 |
Valuation: 24x FY28E EPS = ₹17,832; add ₹562 treasury = ₹18,394 → ₹18,500
Upside from current: +41.5%
5.5 Probability-Weighted Target Price
PWP = (0.20 × ₹11,500) + (0.55 × ₹15,200) + (0.25 × ₹18,500) = ₹2,300 + ₹8,360 + ₹4,625 = ₹15,285 ≈ ₹15,300
12-month probability-weighted price target: ₹15,300 (+17% from ₹13,073)
6. Risk Assessment Matrix
| Risk | Description | Probability | Impact | Mitigant |
|---|---|---|---|---|
| 1. SUV market share structural loss | Mahindra, Tata, Hyundai continue gaining UV share; Maruti UV share stagnates at ~24-25%; ASP expansion capped | HIGH | HIGH | New 7-seater Grand Vitara, Fronx facelift, micro-SUV (FY27); e-VITARA; aggressive pricing on existing SUVs |
| 2. Royalty escalation | Suzuki Motor Japan increases royalty % as platform upgrades accelerate (EV, hybrid); unconfirmed at ~5-6% of sales but consensus estimates suggest ~₹10,000+ Cr in FY27E | MEDIUM | HIGH | No effective mitigant; royalty rate fixed by parent company; minority shareholders structurally disadvantaged |
| 3. Input cost resurgence | Steel, aluminium, palladium/rhodium for BS-VI catalysts spike; RM/sales ratio spikes again after normalisation | MEDIUM | HIGH | Forward procurement; modular platform design reducing unique parts; CNG mix (lower precious metal requirements vs petrol) |
| 4. e-VITARA adoption risk | BaaS model too complex; battery supply from Suzuki/Toyota constrained; charging infra perception gap; Tata brand equity in EVs too strong to dislodge | MEDIUM | MEDIUM | Price-aggressive BaaS (₹10.99 lakh upfront); 1,500+ EV-ready dealerships; 543km range; 2,000+ charging points in 1,100+ cities |
| 5. Export concentration/geopolitical | Middle East, ASEAN demand weakens; rupee appreciates sharply vs export currency basket; UBS flags ongoing geopolitical conflicts affecting end-market demand | MEDIUM | MEDIUM | Geographic diversification of export markets; 24 countries; volume can flex between domestic and export |
| 6. Kharkhoda capacity ramp risk | New capacity (2.5 lakh units in FY27) comes online faster than demand absorption; inventory builds; discounts required to clear; working capital pressures | LOW-MEDIUM | MEDIUM | 1.9 lakh pending orders as of April 2026 earnings call; record monthly volumes (May 2026: 242,688 units) validating demand |
| 7. GST reversal | September 2025 GST restructuring (18% on small cars) could be reversed or modified in upcoming Union Budget | LOW | HIGH | Political cost of reversing a popular consumer benefit is high; unlikely pre-election year |
| 8. Management transition | CEO Hisashi Takeuchi (Japanese national, Suzuki deputation) eventual succession — strategy continuity risk for India-specific decisions on EV investment pace, export mix, pricing | LOW | MEDIUM | Suzuki Motor's institutional commitment to India market is structural (85%+ of India PV operations); Japan parent alignment |
| 9. ESG — EV transition pace | ESG investor pressure as fossil-fuel ICE volumes grow 8%+ while EVs remain sub-1% of total mix | MEDIUM | LOW-MEDIUM | e-VITARA launch; flex-fuel Wagon R (E100 capable); CNG portfolio already reducing per-unit emissions |
7. Investment Recommendation
Rating: HOLD | Conviction: 2/5
12-month probability-weighted target: ₹15,300 (+17%)
Bear/Base/Bull: ₹11,500 / ₹15,200 / ₹18,500
At ₹13,073, Maruti offers a modest 17% 12-month return on a probability-weighted basis, with an asymmetric risk profile tilted toward the bear scenario being more painful (-12%) than the bull scenario is exciting (+41%). For a patient long-term investor who can hold through a Q1 FY27 earnings print (expected July 2026), the stock offers a reasonable risk-reward. For a 12-month institutional mandate focused on conviction positions, the near-term catalyst schedule (Q1 FY27 results, e-VITARA monthly sales data, H1 FY27 management commentary on margin recovery) creates a better entry window post-Q1 results confirmation.
Position sizing: 0.75-1.5% of an Indian equity sleeve. Not a high-conviction overweight; appropriate as a core holding in a diversified India auto/infrastructure basket.
Entry strategy: Accumulate between ₹12,000-13,500 on broad India market weakness or auto sector rotation. ₹12,000 represents ~23x FY27E EPS in the base case — attractive entry. Below ₹12,000, the stock starts pricing in bear scenario outcomes.
Exit strategy:
- Profit-take at ₹16,500-17,000 (roughly 26-27x FY27E EPS base)
- Hard stop at ₹11,200 (-14% from current) — below this level, the market is pricing in a structural margin re-rating to sub-11%, which would require a fundamental thesis reassessment
- Thesis-break triggers: (1) two consecutive quarters of EBITDA margin below 11%; (2) Mahindra market share exceeding 16% while Maruti falls below 37%; (3) e-VITARA monthly volumes below 3,000 units by Q3 FY27 with no signs of scaling
8. Key Catalysts & Monitoring
Near-Term (0-6 Months)
| Catalyst | Direction | Date/Timeline | Conviction |
|---|---|---|---|
| Q1 FY27 results (Apr-Jun 2026) | Binary — margin trough confirmation | Late July 2026 | HIGH — single most important near-term data point |
| e-VITARA monthly sales data (post-July supply ramp) | Positive if >5,000 units/month | July-September 2026 | HIGH |
| June 2026 price hike flow-through | Positive (ASP expansion ~₹12,000-15,000 blended) | Already announced; Q1 FY27 impact | MEDIUM |
| Fronx facelift + Brezza facelift launches | Positive (volume + ASP) | H2 FY26-H1 FY27 | MEDIUM |
| Monthly volume data (continuing all-time high trend) | Positive if >230,000 units/month | Monthly | MEDIUM |
Medium-Term (6-18 Months)
| Catalyst | Direction | Timeline | Conviction |
|---|---|---|---|
| Kharkhoda full capacity utilisation (500,000 units/year phase 1+2 combined) | Positive (operating leverage) | FY27-FY28 | HIGH |
| 7-seater Grand Vitara launch | Positive (₹18-25 lakh ASP; fills gap vs Mahindra Scorpio/XUV700) | Late 2026/Early 2027 | MEDIUM |
| New Micro SUV (Y43 platform, replaces Ignis) | Positive (new entry segment, 1.0L turbo + CNG) | H1 FY27 | MEDIUM |
| EV MPV (YMC platform, e-VITARA underpinning) | Positive/Binary (large format EV = significant capital; risk of pricing vs demand mismatch) | Late 2026-2027 | LOW-MEDIUM |
Long-Term (18+ Months)
| Catalyst | Direction | Timeline | Conviction |
|---|---|---|---|
| Path to 40 lakh units capacity by 2030 | Positive — structural growth anchored | FY28-FY30 | HIGH (management committed) |
| Suzuki global EV platform localisation | Positive/Transformational (if Toyota hybrid tech increasingly shared; 49kWh/61kWh battery localisation) | FY28-FY30 | MEDIUM |
| India PV penetration reaching 30+ vehicles per 1,000 population (from ~25 currently) | Positive structural tailwind | 2028-2032 | HIGH conviction on direction, uncertain timing |
| CNG superiority in hatchback/small-car segment despite EV push | Positive (Maruti's CNG share ~25% of domestic volume; no competitor has comparable CNG depth) | Ongoing | HIGH |
9. Street Pulse — Last 30 Days (Integrated from a 30-day social-sentiment sweep Research)
Research conducted June 11, 2026. Sources: X, Reddit, YouTube, HN a 30-day social-sentiment sweep.
9.1 "Revenue beats, margin disappoints" — The Dominant Frame
[@zerodhamarkets](https://x.com/zerodhamarkets/status/2059241237132234775) on May 26, 2026 crystallised the community debate: "That fragmented demand is visible in Q4 FY26 results of India's three largest passenger vehicle companies, Maruti Suzuki, Hyundai India, and Tata Motors. Everyone sold more cars. But who is buying them, what they are buying, and what it costs to make those cars — that is where the real story is." This framing — volume good, profitability suspect — is how the Indian investing community is reading MARUTI. It has ~8 likes and 1 repost but driven by Zerodha's credible market commentary account.
Verdict: Street consensus is correct to flag the mix/profitability tension. But the market is forward-looking, and the June price hike + record volumes in April-May FY27 have already begun addressing this. The "margin disappoints" narrative is a lagging read on Q4 FY26 data.
Sentiment: bearish on near-term margins, mixed on medium-term
9.2 June Price Hike Read as Margin Restoration Signal
[@SBK_analysis](https://x.com/SBK_analysis/status/2057641078111731787) on May 22 flagged: "Maruti Suzuki to hike car prices by up to ₹30,000 from June" as a key market trigger. Across auto media communities and Reddit discussions (r/IndianStockMarket, per engine data), the read is consistent: this is cost pass-through, not demand inflation. Morgan Stanley's commentary that "margins should trough in Q1 FY27" is being repeated verbatim in investor discussions.
Verdict: The price hike is a genuine positive signal. Historical pattern shows Maruti hikes prices 1-2 times per year; the June 2026 hike is the first of FY27 and represents approximately ₹12,000-15,000 blended ASP uplift on a per-unit basis across the full model lineup. This should contribute ~80-100bps of EBITDA margin expansion relative to Q4 FY26 exit rate, confirming the trough thesis.
Sentiment: bullish on pricing power, consistent with buy thesis
9.3 e-VITARA: Cautious Optimism, Supply-Constrained Narrative
X data ([@alfa_finde81983](https://x.com/alfa_finde81983/status/2062462758944436716)) and YouTube channels (Dark Trading View, NDTV Profit, each receiving modest but engaged viewership for MARUTI stock content) reflect an investor community that is watching the e-VITARA carefully but not yet excited. Community awareness is that deliveries are constrained to July 2026, and the BaaS model's complexity is a perceived risk. The 6-8 week waiting period — while indicating demand — is also seen as a supply-side constraint rather than demand strength.
Verdict: The market is under-pricing e-VITARA optionality. Maruti's distribution network (1,500+ EV-ready dealers) and the BaaS pricing (₹10.99 lakh upfront, ₹3.99/km battery rental) are significantly more accessible than Tesla's or Tata's direct-sales EV model. Post-July supply ramp will be the key datapoint. If volumes hit 5,000+ units/month by Q2 FY27, the EV re-rating narrative activates.
Sentiment: mixed, watching for supply unlock
9.4 Market Share Debate — Structural vs Cyclical Loss
On Reddit (r/IndiaInvestments and r/IndianStockMarket threads, though most MARUTI discussion skewed to consumer/product vs. investor communities per engine output), and across X, the SUV market share loss to Mahindra is debated. Bear camp: the gap is structural — Mahindra builds aspirational status products (Scorpio-N, Thar, XUV700) while Maruti's SUVs (Brezza, Fronx) are practical/value choices. Bulls argue: Maruti's next wave (7-seater Grand Vitara, Fronx facelift with stronger styling) addresses this; the CNG stronghold in small cars is not replicable.
Verdict: Both camps have merit. The market share loss IS structural in the premium/lifestyle SUV sub-segment. Maruti cannot out-aspirational Mahindra with its current brand equity. But Maruti's dominance in the ₹5-12 lakh segment (where India's volume lives), combined with CNG advantage, export muscle, and rural reach, means the absolute volume floor is higher than bears acknowledge. The recovery to 50% market share by FY31 (management target) is implausible without a new premium identity, but stabilisation at 38-40% with growing absolute volumes is very achievable.
Sentiment: bearish on market share trajectory, bullish on absolute volume
9.5 Sell-Side Consensus — Firmly Bullish at Current Price
Per [Investing.com](https://in.investing.com/equities/maruti-suzuki-india-consensus-estimates): 40 analysts covering MARUTI; 34 Buy, 4 Hold, 2 Sell. Average 12-month target ₹16,744. Range: ₹13,561 (bear) to ₹19,050 (bull). Goldman Sachs 26% upside thesis on record volumes + EV optionality + price hike. Morgan Stanley on margin trough. UBS cautious on export demand.
Verdict: Sell-side is structurally bullish (34/40 Buy) with a 22%+ implied upside from ₹13,073. The key conviction varies: Goldman's bull case rests on ASP expansion and EV option value, while UBS's more cautious stance reflects export uncertainty and margin recovery timing. The consensus target ₹16,744 aligns with our base case of ₹15,200-15,300 — slightly higher than our probability-weighted estimate, suggesting we are slightly below consensus on the margin recovery timeline.
Sentiment: bullish (34/40 Buy); 22% implied upside to street mean
10. Final Investment Summary
Thesis:
- Record volumes (242,688 units in May 2026, highest-ever) validate demand runway; FY27 exit rate should approach 2.8-3.0M annual units with Kharkhoda Phase 2 online — operating leverage is real, only a matter of timing
- June 2026 price hike + commodity cost stabilisation creates a credible margin recovery path to 13-14% EBITDA by FY28E — if confirmed in Q1 FY27 results (July 2026), the stock re-rates to ₹15,000-16,000 in the following quarter
- Zero net debt, ₹16,937 Cr liquid treasury corpus, ₹19,100 Cr OCF, and funded ₹14,000 Cr capex plan mean the balance sheet risk is essentially zero — the only investment risk is earnings quality and growth pace
Key Risks:
- SUV market share structural erosion (38.93% overall, ~24.5% UV sub-segment) is unlikely to reverse materially before FY28; Mahindra's platform cadence is accelerating, not slowing
- Royalty to Suzuki Japan (~5-6% of net sales, est. ₹10,000+ Cr in FY27E) is a permanent margin ceiling that fundamentally prevents Maruti from achieving Mahindra-level EBITDA margins; minority shareholders structurally subsidise the Japanese parent
- e-VITARA's BaaS model complexity and Tata's 3-year EV head-start create real risk that Maruti's EV credibility remains niche through FY28 — the re-rating that bulls are pricing in may not materialise within the 12-month investment horizon
Verdict: HOLD with conviction 2/5. 12-month probability-weighted target ₹15,300 (+17%). Position as a 0.75-1.5% India equity core holding; upgrade to BUY with conviction 3/5 if Q1 FY27 EBITDA margin prints above 12.8% and e-VITARA volumes post-July 2026 exceed 5,000 units/month.
Appendix: FY26 Key Operational Statistics
| Metric | FY26 | FY25 | YoY Change |
|---|---|---|---|
| Total Units Sold | 2,422,713 | 2,234,266 | +8.4% |
| Domestic (PV) | 1,974,939 | 1,901,664 | +3.9% |
| Exports | 447,774 | 332,602 | +34.6% |
| SUV Units (domestic) | ~760,987 | ~693,000 est. | +9.8% |
| UV Market Share | ~24.5% | ~26.0% | -150bps |
| Overall PV Market Share | 38.93% | ~40.5% | -157bps |
| Net Sales (₹ Cr) | 183,316 | 152,913 | +19.9% |
| EBITDA (₹ Cr) | 21,456 | 20,224 | +6.1% |
| EBITDA Margin | 11.7% | 13.2% | -150bps |
| PAT (₹ Cr) | 14,680 | 14,500 | +1.2% |
| EPS (₹) | 467 | 461 | +1.3% |
| Other Income (₹ Cr) | 4,357 | ~5,020 est. | -13.2% |
| OCF (₹ Cr) | 19,100 | ~16,181 est. | +18.0% |
| Capex (₹ Cr) | 10,398 | ~7,500 est. | +38.6% |
| FCF (₹ Cr) | ~8,702 | ~8,681 est. | flat |
| Dividend (₹/share) | 140 | 135 | +3.7% |
| Net Cash / Liquid Investments | 16,937 | ~14,500 est. | +16.8% |
| ROCE | 19% | 22% | -300bps |
| ROE | 14% | ~17% est. | -300bps |
Prepared by Jeff the Financier | Jeff Web (jeff.upamanyuacharya.com) | June 11, 2026 Data sources: Screener.in (consolidated), ChartAlert Q4 FY26 results, InvestYwise FY26 report, MarketsMojo Q4 FY26 analysis, Rushlane FY26 market share data, official Maruti Suzuki press releases (marutisuzuki.com/corporate/investors), Outlook Business, Business Standard, DriveSpark, Autocar India, a 30-day social-sentiment sweep output (June 11, 2026).
Indian Energy Exchange Ltd
HOLD/ACCUMULATE: India's best-quality exchange business at a historic valuation discount purely due to regulatory binary — RTM's exemption from coupling is the non-consensus insight that makes current prices asymmetrically attractive for patient capital.
The numbers that matter
The KPI set chosen for this specific business model — hover any card; every figure cross-verified against at least two sources.
Financial trajectory & forecast
| FY22 | FY23 | FY24 | FY25 | FY26 | FY27E | FY28E | |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 431 | 401 | 449 | 537 | 616 | 710 | 810 |
| EBITDA margin (%) | 84.5 | 83.8 | 83.9 | 84.5 | 84.4 | 84.0 | 83.5 |
| PAT (₹ Cr) | 309 | 306 | 351 | 429 | 493 | 558 | 630 |
| EPS (₹) | 3.44 | 3.43 | 3.93 | 4.81 | 5.53 | 6.26 | 7.07 |
Amber columns are Jeff estimates (FY27E / FY28E). FY = fiscal year ending March.
Forecast assumptions
- Volume growth: 15% FY27E, 14% FY28E (May 2026 at 18.6% YoY validates trajectory)
- Transaction fee: 2 paise/unit maintained throughout forecast period (no CERC fee cut assumed in base case)
- Market coupling formal regulations NOT implemented in forecast period (delayed to FY28 earliest)
- RTM continues 25-30% CAGR as structural share of total volumes grows
- Non-operating income (investment returns): Rs 130 Cr FY27E, Rs 140 Cr FY28E
- Tax rate: 25.17% (new regime maintained)
- Minimal contribution from coal exchange (pre-revenue) or ICX optionality in base case
The operating engine
RTM (+41% YoY in FY26) is structurally exempt from market coupling on a 48-session logistical barrier — the non-consensus core of the thesis. FY27E/FY28E stacks are Jeff estimates.
Scenarios & price ladder
Click a scenario to read its narrative. Marker sizes scale with assigned probability; the amber diamond is the probability-weighted 12-month target.
Valuation & relative read
| Peer | P/E | EV/EBITDA | Read |
|---|---|---|---|
| MCX.NS (Multi Commodity Exchange) | 38.0x | 30.0x | Commodity exchange monopoly; comparable moat; no regulatory coupling risk; richly valued |
| BSE.NS (Bombay Stock Exchange) | 55.0x | 45.0x | Stock exchange; stronger regulatory protection; no equivalent structural threat |
| CDSL.NS (Central Depository Services) | 48.0x | 40.0x | Depository monopoly; highest-quality moat in Indian exchange infrastructure |
| PXIL (Power Exchange India, unlisted) | 6.3x | — | Direct competitor; 5% market share; deeply discounted as subscale challenger |
Street pulse — the last 30 days
What investors actually argued about between 11 May and 10 June 2026 — Reddit, X, YouTube and the financial web — each debate answered with data, not vibes.
Risks & catalysts
Key risks
- CERC notifies final coupling regulations (Regulation 39) including RTM and mandates 1.5 paise/unit fee — combined bear case implies 30% EPS erosion
- Grid India MCO operational from Q2 FY27, IEX DAM share erodes faster than volume growth compensates (to below 60% by FY29)
- RTM coupling implemented despite 48-session logistical barrier — eliminates the key non-consensus bull argument
- Structural power surplus from 55 GW+ annual capacity additions suppresses clearing prices below Rs 3/unit, reducing buyer willingness to pay PPAs' opportunity cost
- Ministry of Coal regulations delayed beyond FY29, making coal exchange optionality worthless in the near term
- FII exit if Indian macro deteriorates (INR weakness, EM outflows) reduces institutional support below 14%
- Management commentary in Q1 FY27 (July 2026) turns cautious on regulatory timeline — negative stock signal
- European CBAM implementation delays reduce ICX I-REC demand from Indian exporters
Key catalysts
- CERC final coupling regulations exclude RTM and maintain 2 paise fee — re-rates stock to Rs 145-155
- IEX's legal challenge to final regulations succeeds at APTEL — delays implementation 12-18 months; re-rates to Rs 160+
- Q1 FY27 volumes track 18%+ YoY (July 2026 data) — validates FY27 guidance and reduces growth-miss risk
- Ministry of Coal releases final coal exchange regulations — triggers coal exchange optionality re-rating
- Data centre / AI power demand visibly lifting RTM volumes in Q2 FY27 — structural demand narrative strengthens
- IGX gas volumes recover post-Middle East disruption in Q1 FY27; FY27 tracking 25%+ growth
- SEBI/NSE listing of HPX or PXIL reveals their actual valuations as deeply subscale — reinforces IEX's premium
- India announces accelerated renewable energy targets (700 GW by 2030) — drives green market volume re-rating
The full deep-dive
Read the complete institutional report — Indian Energy Exchange Ltd5,339 words
Indian Energy Exchange Ltd (NSE: IEX) — Institutional Equity Research
Jeff the Financier | Prepared: 2026-06-11 | IIM-Ahmedabad MBA Series
1. Executive Summary & Investment Thesis
Thesis: IEX is India's dominant electricity exchange with a structurally enviable 85-90% market share, ~85% EBITDA margins, zero net debt, and ~₹1,993 Cr in investments on a ₹10,594 Cr market cap — yet the stock has shed nearly 44% from its 52-week high of ₹215.40 to ₹119 as of June 2026, entirely on regulatory overhang. The market-coupling debate is THE existential question: CERC's April 2026 draft (Grid India as MCO) has the potential to commoditize DAM price discovery, eroding IEX's liquidity network effect and creating a pathway for fee rationalisation. The critical insight, however, is that coupling has been in a regulatory fog since July 2025 — 11 months of delay — and APTEL's February 2026 ruling explicitly requires fresh formal regulations before implementation. At ₹119, a 21.5x trailing P/E on a business earning 51% ROCE is pricing in a catastrophic scenario that requires both full coupling AND structural fee reduction to materialise simultaneously. The base case is more nuanced, and the risk/reward at current prices is asymmetrically attractive for patient capital.
Rating: HOLD/ACCUMULATE on dips | Conviction: 3/5 (binary regulatory risk prevents higher conviction)
Current Price: ₹119 (June 11, 2026; Source: Screener.in, as of June 11, 2026)
52-Week Range: ₹114.60 (low) — ₹215.40 (high)
Market Cap: ₹10,594 Cr
12-Month Price Targets:
- Bear: ₹85 (-29% from current) — Full market coupling + fee cut to 1.5 paise
- Base: ₹140 (+18%) — Coupling delayed 18-24 months, volumes compound at 15%
- Bull: ₹185 (+56%) — Coupling regulations challenged/diluted, coal exchange optionality re-rated
Top Value Drivers:
- RTM volume compounding at 41% YoY — the segment least exposed to coupling (48 daily auctions make central coupling operationally impractical)
- Renewables penetration secular tailwind driving exchange-traded share from 8% to 15%+ of India's 1,830 BU total consumption
- Coal exchange (incorporated June 1, 2026) + ICX carbon/I-REC (179 lakh I-RECs in FY26, +200% YoY) — unpriced optionality worth 10-15% of market cap at maturity
Top Risks:
- CERC finalises coupling regulations in H2 FY27, Grid India operationalised as MCO — DAM market share could erode to 60-65% by FY30
- CERC mandates uniform 1.5 paise fee across all segments, reducing revenue per BU by ~25% without volume offset
- Macro: surplus power supply (55 GW added in FY26) suppresses clearing prices, reducing notional transaction value and potentially the perceived urgency of exchange trading
2. Core Business Performance & Market Position
2a. Revenue Decomposition
IEX operates a capital-light exchange model with two economic engines:
Transaction fees (≈78-80% of standalone revenue): IEX charges 2 paise/kWh from both buyer and seller (round-trip = 4 paise/kWh = ₹400/MWh). This applies to DAM, RTM, and most TAM segments. The fee is CERC-regulated with a ceiling of 2 paise; exchanges currently price at the ceiling.
Certificate trading & other (≈15-20%): REC trading (187 lakh RECs in FY26, +5% YoY), ESCert trading under PAT scheme, membership fees, and connectivity charges. These provide income diversification with different regulatory risk profiles from electricity trading fees.
Consolidated FY26 Revenue Breakdown (estimated from public disclosures):
- Standalone IEX (electricity + REC + ESCert): ₹608 Cr
- IGX (gas exchange, subsidiary): Approximately ₹35-40 Cr revenue (extrapolated from FY26 PAT of ₹41.9 Cr at ~85% margin)
- ICX (carbon exchange, subsidiary): ₹7.7 Cr
- Consolidated total income: ₹746.95 Cr (FY26 actual)
Historical Revenue & PAT (₹ Cr):
| Fiscal Year | Revenue | EBITDA | EBITDA Margin | PAT | EPS (₹) |
|---|---|---|---|---|---|
| FY22 | 431 | 364 | 84.5% | 309 | 3.44 |
| FY23 | 401 | 336 | 83.8% | 306 | 3.43 |
| FY24 | 449 | 377 | 83.9% | 351 | 3.93 |
| FY25 | 537 | 454 | 84.5% | 429 | 4.81 |
| FY26 | 616 | 520 | 84.4% | 493 | 5.53 |
Source: Screener.in consolidated; operating profit used as EBITDA proxy (IEX has minimal D&A). FY26 actuals confirmed via BSE filing April 23, 2026.
Key Growth Observations:
- FY23 revenue dip (-7% YoY) vs. FY22 driven by falling DAM clearing prices, not volume contraction — a structural feature of this business model: fee is per-unit, not per-rupee
- FY25 and FY26 volume acceleration (19% and 17% YoY respectively) drove the revenue reacceleration
- Revenue growth consistently lags volume growth by 3-5 percentage points because clearing prices have been structurally falling (DAM -13.7% YoY in FY26, RTM -16%), reflecting India's massive capacity addition
2b. Volume Trajectory — The Right KPI
Traded volumes are the primary revenue driver and the correct operating KPI. Market share among exchanges is the moat indicator.
FY26 Volume by Segment (BU):
| Segment | FY26 BU | FY25 BU | Growth | Fee Exposure |
|---|---|---|---|---|
| Day-Ahead Market (DAM) | 62.78 | 61.31 | +2.4% | High (coupling target) |
| Real-Time Market (RTM) | 54.85 | 38.90 | +41.0% | Moderate (coupling impractical) |
| Term-Ahead Market (TAM) | 12.72 | 11.77 | +8.1% | Low (longer tenor) |
| Green Market (G-DAM + GTAM) | 10.78 | 8.75 | +23.2% | Moderate |
| Total | 141.13 | 120.73 | +17.0% |
Source: IEX press releases; Business Standard (April 6, 2026); Mercom India (April 2026).
Key volume insights:
- RTM's 41% surge is the most significant structural development. RTM operates as 48 half-hourly auctions daily — coupling RTM is logistically near-impossible with the round-robin MCO model CERC proposed, because each exchange would serve as MCO every third session, requiring sub-minute handoffs. Management flagged this explicitly in the Q4 FY26 call.
- DAM's meager 2.4% growth despite market-wide demand up 11.5% YoY indicates price-responsive buyers shifting away from spot purchasing when clearing prices fell; the structural penetration growth in DAM is now RTM-led.
- Green Market +23% signals India's renewable energy transition is creating new exchange volume independent of fossil-fuel dispatch.
May 2026 Monthly Data (earliest read on FY27):
- Total: 12,983 MU (18.6% YoY growth)
- DAM: 4,417 MU (+24.9%)
- RTM: 5,529 MU (+15.9%)
- TAM: 2,004 MU (+16.1%)
- Green: 1,034 MU (+13.0%)
Source: IEX press release; Business Standard June 3, 2026.
The May print confirms FY27 is tracking at 17-19% volume growth, ahead of management's "15-20%" guidance.
2c. Market Share & Competitive Position
IEX commands ~85-90% of exchange-traded electricity volumes. In DAM specifically, IEX's FY24 share was 99.9%+ (PXIL: 0.079 BU vs. IEX: 53.38 BU per CERC Annual Report 2023-24). HPX has focused on TAM where it captured ~33% of segment volumes within two years of launch.
Competitor Overview:
| Exchange | Ownership | Core Strength | FY26 Est. Share | Listed? |
|---|---|---|---|---|
| IEX | Publicly traded | DAM + RTM dominance, liquidity depth | ~85% | NSE/BSE |
| PXIL | BSE + NCDEX | REC trading, institutional relationships | ~5% | Unlisted |
| HPX | Adani + others | TAM segment, recent entrant | ~10% | Unlisted |
Market coupling is designed to erode IEX's network-effect advantage in DAM by ensuring the same price discovery regardless of which exchange you trade on. The economic analogy is UPI standardising payments — the network effect moat is eliminated, but volume can still grow. The real question becomes: does IEX's operational infrastructure, relationships, and brand allow it to defend >60% share even in a coupled market?
2d. Clearing Price Trend (Critical Risk Driver)
Clearing prices have declined materially and structurally, but this has NOT hurt volumes — it has boosted them.
| Period | DAM Avg Price (₹/unit) | RTM Avg Price (₹/unit) | YoY Change |
|---|---|---|---|
| Q1 FY26 | ~4.30 | ~4.00 | ~-8% |
| Q2 FY26 | 3.93 | 3.51 | -12.5%, -16.1% |
| Q3 FY26 | 3.22 | 3.26 | -13.2%, -11.6% |
| Q4 FY26 | 3.89 | 3.68 | -12.2%, -15.0% |
| FY26 Full Year | 3.86 | 3.59 | -13.7%, -16.0% |
Source: Mercom India quarterly reports; IEX press releases.
The mechanism: lower prices stimulate demand from discoms, industrial buyers, and open-access consumers who were previously buying from PPAs at higher rates. Exchange-traded power becomes comparatively attractive, driving penetration gains. This is the key non-consensus insight — IEX's revenue per BU is fixed at ~4 paise round-trip regardless of clearing price; falling prices help volume without hurting unit economics.
India added ~55 GW of new capacity in FY26 (predominantly renewables), creating structural surplus that is likely to keep clearing prices compressed for 2-3 years. This is volume-bullish and revenue-neutral for IEX's core transaction fee.
3. Business Unit / Segment Analysis & SOTP Valuation
3a. Core Electricity Exchange (IEX standalone)
- Revenue FY26: ₹608 Cr (≈81% of consolidated income)
- EBITDA Margin: ~85% (₹517 Cr EBITDA estimated)
- PAT: ₹474 Cr (standalone FY26)
- Volume CAGR FY23-FY26: ~16% (from 120 BU baseline projected from public data)
- Competitive position: Near-monopoly in DAM; ~85% RTM share; dominant but challenged in TAM
Segment-appropriate multiple: Exchange businesses globally trade at 25-40x earnings in stable regulatory environments. Given the coupling overhang, I apply a risk-adjusted 22-25x FY27E EPS multiple.
At ₹5.53 FY26 EPS and assuming 15% growth to ₹6.37 FY27E, a 22x multiple gives ₹140/share (base) and 25x gives ₹159/share.
3b. IGX — Indian Gas Exchange
- FY26 PAT: ₹41.9 Cr (+35% YoY)
- FY26 Gas Volume: 76.8 mn MMBtu (+28% YoY)
- Q4 FY26 gas volume: 18.6 mn MMBtu (-8% QoQ due to Middle East disruptions)
- Strategic rationale: India targets 15% gas in energy mix by 2030 from 6% now; IGX is the exchange infrastructure enabler
SOTP value: At 30x earnings (fast-growing, early-stage exchange, less regulatory risk), IGX is worth ~₹1,257 Cr or ~₹14.1/share.
3c. ICX — International Carbon Exchange (I-REC + ESG)
- FY26 Revenue: ₹7.7 Cr (+126% YoY)
- FY26 I-REC issuances: 179 lakh (+200%+ YoY)
- Q4 FY26 I-REC: 46 lakh (+29% YoY)
ICX is genuinely embryonic — ₹7.7 Cr revenue on a ₹10,594 Cr market cap. But I-REC demand from Indian IT/manufacturing exporters facing European carbon border mechanisms (CBAM) is a structural demand driver over FY27-FY30. At current trajectory (100%+ revenue CAGR), ICX could be a ₹50-100 Cr revenue business by FY29.
SOTP value: At current scale, ICX is worth ₹150-300 Cr in optionality terms (nominal, highly speculative).
3d. Indian Coal Exchange (incorporated June 1, 2026)
The most recent optionality: ~80-90 million tonnes of coal currently traded via government e-auctions and 150 million tonnes of imports represent a potential addressable market. Ministry of Coal regulations are the gating factor (not yet finalised). No revenue yet.
SOTP value: Option value only, ₹0 for base case; ₹500-1,000 Cr in 3-5 year bull case.
SOTP Summary
| Segment | EV/Earnings Basis | Implied Value (₹ Cr) | Per Share (₹) |
|---|---|---|---|
| Core electricity exchange | 22-25x FY27E PAT (₹474 Cr base) | 10,428-11,850 | 117-133 |
| IGX (gas) | 30x FY26 PAT (₹41.9 Cr) | 1,257 | 14.1 |
| ICX (carbon) | Optionality value | 200-400 | 2.2-4.5 |
| Coal exchange | Optionality, pre-revenue | 0-500 | 0-5.6 |
| Net cash/investments | Book value | 1,982 Cr (₹22.2/sh) | 22.2 |
| Total SOTP base | ~13,869 Cr | ~155 |
Current market cap of ₹10,594 Cr trades at a ~24% discount to base SOTP, implying the market assigns negative value to IGX + ICX + coal optionality (they're all priced as worthless) while also pricing the core at a ~20% discount to fair value. This is the bear-case compression embedded in current prices.
4. Market Expectations & Reverse Valuation
Reverse-engineering the current price (₹119):
Using a 5-year DCF with 10% WACC (appropriate for Indian mid-cap with strong balance sheet but binary regulatory risk):
- Implied FY26-FY31 Revenue CAGR: ~6% (vs. my base case of 12%)
- Implied terminal EBITDA margin: 70% (vs. actual 84%)
- Implied terminal P/E exit: 18x (vs. 5-year average ~45x, even post-crash)
The market is pricing a scenario of material margin erosion AND volume growth disappointment simultaneously. This is an unlikely combination — the historical evidence from REC market coupling (where margins remained at ₹0.036-0.037/unit despite competition) suggests volume can grow even with market share loss.
Peer Multiples (Power & Infrastructure Exchange Businesses):
| Company | Business | P/E | EV/EBITDA | FCF Yield | Notes |
|---|---|---|---|---|---|
| IEX.NS | Power exchange | 21.5x (FY26) | ~20x | ~4.5% | Regulatory overhang, 85% margin |
| MCX.NS | Commodity exchange | 38x | ~30x | ~2.8% | Comparable monopoly exchange |
| BSE.NS | Stock exchange | 55x | ~45x | ~1.5% | Stronger moat, no coupling threat |
| CDSL.NS | Depository | 48x | ~40x | ~2.0% | Near-monopoly infrastructure |
| CME Group (US) | Exchange | 26x | ~22x | ~3.5% | Mature, diversified |
| National Stock Exchange (India, unlisted) | Stock exchange | ~35x est. | — | — | Most comparable monopoly |
IEX at 21.5x is the cheapest exchange business in India by a wide margin despite having a higher ROCE (51%) than any of its peers. The discount is entirely coupling-risk. If coupling fears ease, re-rating to 30x+ is plausible, implying ₹185+ on FY27E EPS.
Street Pulse Integration (a 30-day social-sentiment sweep, June 2026):
The [r/IndianStockMarket](https://www.reddit.com/r/IndianStockMarket/comments/1ts0u0m/will_iex_dominate_in_future_like_bsense_dominate/) thread asking "Will IEX dominate like BSE/NSE?" (30 days ago, high engagement) crystallises the exact investment debate. The community answer: "yes, if exchange penetration grows; uncertain if market coupling eliminates pricing power." This is precisely the right framing. X consensus groups IEX with CDSL and MCX as monopoly-type businesses (per [@damodara_SEBIRA](https://x.com/damodara_SEBIRA/status/2064011569613136115), 18 likes, June 8, 2026) — but at a discount to those peers precisely because the moat-erosion risk is unique to IEX.
The anti-Akshat contrarian narrative (per [@ASagotia](https://x.com/ASagotia/status/2062607091152650469): "Don't bet against the market but always bet against Akshat — be it IEX...") signals the retail contrarian trade is forming but hasn't yet become consensus.
Sentiment verdict on market coupling: consensus = bearish, reality = overstated bear case. The draft regulations were issued April 2026, public comment period closed May 16, and final regulations are NOT yet notified. Actual MCO implementation has been deferred at least once and faces significant operational challenges for RTM.
5. Scenario-Based DCF Valuation
WACC: 10.5% (beta ~0.9, equity risk premium 7%, risk-free 6.5%, no debt premium; slightly elevated for regulatory binary)
Terminal growth rate: 5% (India GDP nominal ~10%, exchange penetration growth offsetting any market-share loss)
Bear Case (Probability: 30%) — Full Coupling, Fee Cut
Assumptions:
- Market coupling implemented for DAM by Q2 FY27, RTM by Q4 FY27
- CERC mandates uniform fee of 1.5 paise/unit (25% cut from 2 paise)
- IEX DAM market share falls from 89% to 60% by FY29 as HPX/PXIL gain under neutral pricing
- Volume growth slows to 8% CAGR (structural demand growth offset by share loss)
- Revenue CAGR FY26-FY30: ~5%
- Terminal EBITDA margin: 72% (margin compression from fixed-cost base on lower fee)
- Exit P/E: 18x
Bear implied equity value: ₹85/share (-29% from current)
Key assumption: 30% EPS reduction per Axis Capital analysis ("if coupling had been in FY25, EPS would have been 30% lower"). At FY26 EPS of ₹5.53, bear EPS = ₹3.87; terminal value discounted back gives ₹85.
Base Case (Probability: 50%) — Coupling Delayed, Partial Implementation
Assumptions:
- Formal coupling regulations notified in H2 FY27; DAM implementation in FY28
- Fee rationalisation minimal (political pushback from IEX lobbying; 1.75-2 paise range maintained)
- IEX market share moderates to 75-78% in DAM by FY29 (network effects partially retain share)
- RTM volume continues 25-30% growth CAGR (coupling impractical for RTM)
- Total volume CAGR FY26-FY30: 13%
- Revenue CAGR: 11% (volume growth partially offset by fee stability)
- Terminal EBITDA margin: 82%
- Exit P/E: 22x
FY27E EPS: ₹6.37 (15% growth) → FY28E EPS: ₹7.25 (14% growth)
Base implied equity value: ₹140/share (+18% from current)
Bull Case (Probability: 20%) — Coupling Diluted or Long-Delayed, Diversification Re-rated
Assumptions:
- IEX's legal challenge to coupling regulations succeeds or CERC significantly dilutes the scheme (round-robin limited to DAM only, RTM exempt; fee unchanged)
- Exchange penetration grows from 8% to 14% of India's total power consumption over FY27-FY32
- Coal exchange receives Ministry approval by FY28; IGX continues 25% PAT growth
- Total volume CAGR: 18%
- Revenue CAGR: 16%
- Terminal EBITDA margin: 85%
- Exit P/E: 28x (re-rating toward MCX comparables)
Bull EPS trajectory: ₹7.00 FY27E → ₹8.50 FY28E
Bull implied equity value: ₹185/share (+56% from current)
Probability-Weighted Target (12-Month)
PWP = (₹85 × 30%) + (₹140 × 50%) + (₹185 × 20%) = ₹25.5 + ₹70 + ₹37 = ₹132.5
12-month probability-weighted price target: ₹133, representing +12% upside from ₹119.
6. Risk Assessment Matrix
| Risk | Category | Probability | Impact | Mitigant |
|---|---|---|---|---|
| CERC notifies final coupling regs in H2 FY27 | Regulatory | Medium | High | IEX can challenge; operational implementation requires 12+ months post-regulation |
| Fee rationalisation to 1.5 paise | Regulatory | Medium | High | Requires separate regulatory action; CERC said "still at preliminary stage" as of Dec 2025 |
| RTM coupling implementation | Regulatory | Low | High | 48 daily auctions logistically impractical with round-robin MCO; technical barrier is real |
| Clearing price further decline | Market | High | Low | Fee is per-unit not per-rupee; lower prices = more volume. Net neutral at current penetration levels |
| New entrant (HPX 2.0 or government exchange) | Market | Low | Medium | Network effects, technology, and 15-year incumbent relationships are durable barriers |
| Renewable surplus suppressing dispatch | Market | High | Low | More surplus = more need for exchange price discovery; creates volume, not headwinds |
| IGX gas volume disruption (geopolitical) | Execution | Medium | Low | FY26 Q4 already showed recovery path; India LNG import diversification underway |
| ICX regulatory risk (I-REC rules change) | Regulatory | Low | Low | Governed by international bodies, less CERC exposure |
| Coal exchange delayed (Ministry regs) | Execution | High | Low | Coal exchange is not in numbers; delay = no downside to base case |
| Management turnover | ESG | Low | Medium | S.N. Goel as CMD provides continuity; deep bench in power sector expertise |
| India-Pakistan geopolitical escalation | Geopolitical | Low | Medium | Power sector considered essential; exchanges likely continue operations |
| Grid-India MCO operational failure | Market | Medium | Medium | Creates legal grounds for IEX to challenge; perversely bullish if MCO fails |
7. The Market Coupling Question — Deep Dive
What has actually happened (Timeline)
| Date | Event |
|---|---|
| July 23, 2025 | CERC issues DAM coupling direction; IEX stock crashes ~30% intraday |
| August 2025 | IEX files appeal (No. 298/2025) at APTEL |
| September-November 2025 | APTEL admits appeal; adds PXIL and HPX as respondents |
| January 6, 2026 | APTEL makes observations critical of CERC process; IEX surges 9%+ |
| February 13, 2026 | APTEL disposes IEX appeal — does NOT set aside CERC directions, but clarifies coupling CANNOT proceed until formal Regulation 39 regulations are notified |
| April 2026 | CERC issues draft Second Amendment Regulations 2026 — proposes Grid India as MCO |
| May 16, 2026 | Deadline for stakeholder comments on draft regulations |
| June 1, 2026 | IEX incorporates Indian Coal Exchange subsidiary |
| June 2026 | Final regulations NOT yet notified — implementation status: pending |
Revenue Impact Quantification (Scenarios)
Axis Capital's estimate: If coupling had been in place in FY25, EPS would have been ~30% lower. At FY26 EPS of ₹5.53, this implies ~₹3.87 EPS in a fully-coupled scenario — roughly consistent with a ₹85 bear case at 22x.
Mechanism of revenue impact (two channels):
Channel 1 — Market share loss: Under coupling, all exchanges share the same clearing price. IEX's competitive advantage of deepest liquidity (which attracts the most buyers/sellers creating better prices) is neutralised. Historical precedent from European power markets (Nord Pool vs. smaller peers) shows that coupling reduced dominant exchange share by 15-25 percentage points over 3-5 years, not immediately. In India's early-stage market, the share erosion may be faster or slower — unclear.
Channel 2 — Fee rationalisation: CERC has been studying whether the current 2 paise ceiling should be reduced post-coupling. The draft regulations do not include fee changes, but the Business Today article (December 2025) confirmed CERC is "at preliminary stage" on fee rationalisation discussions. A move to 1.5 paise would be a 25% revenue cut per unit, not offset by volume growth alone.
Non-consensus insight on RTM: RTM is 38.9% of IEX's total volume in FY26 and growing at 41% YoY. RTM operates with 48 half-hourly sessions daily — to implement round-robin MCO for RTM, each of the three exchanges would need to be MCO for 16 sessions per day. The operational feasibility is questionable. Management called RTM coupling "impractical due to tight timelines" in the Q4 FY26 call. If RTM remains uncoupled (plausible), coupling impact falls to DAM only (44% of volumes), materially reducing the bear case severity.
8. KPI Dashboard for Exchange Business Monitoring
Transaction fee realization: At 4 paise/unit round-trip, IEX earns ₹4,000/GWh. FY26 revenue of ₹608 Cr on 141 BU implies realized blended fee of ₹0.043/unit (including non-transaction fee items), roughly consistent with the 4-paise headline.
EBITDA margin: 84.4% in FY26, stable within a tight 83-85% band since FY22. This is one of the highest EBITDA margins in Indian listed equities — a reflection of the asset-light, fixed-cost exchange model where incremental revenue is almost entirely profit.
ROIC: Not explicitly disclosed, but ROCE of 51.4% (FY26) with near-zero debt and ₹1,993 Cr in investments implies NOPAT/invested capital in the 45-55% range. ROIC meaningfully exceeds any reasonable WACC estimate — strong economic value creation.
FCF conversion: FY26 operating cash flow of ₹433 Cr on operating profit of ₹454 Cr = 95% cash conversion (working capital is negative, which is common for exchanges). FCF of ₹418 Cr on market cap of ₹10,594 Cr = 3.9% FCF yield — reasonable but not cheap.
Cash & investments: ₹1,993 Cr in investments + minimal debt (₹11 Cr borrowings) = effectively net cash of ~₹1,980 Cr = ₹22.2/share. Adjusted for cash, core business is trading at ₹97/share on ₹5.53 EPS = 17.5x, which is genuinely cheap for a dominant exchange business.
Dividends & capital return: FY26 dividend = ₹2/share + ₹1.5/share interim = ₹3.5/share total. At ₹119, yield = 2.94%. Payout ratio ~63% of PAT. The remaining FCF accumulates in the investment book — IEX has been steadily building financial assets rather than doing buybacks. This is capital allocation worth watching.
9. FY27E / FY28E Financial Forecasts
Key Assumptions:
- Volume growth: 15% in FY27E (slightly below FY26's 17% given high base), 14% in FY28E → FY27E: 162 BU, FY28E: 185 BU
- Fee realisation: 2 paise maintained throughout (no CERC fee cut in this period)
- Revenue per BU: stable at ~₹0.043/unit (mix of transaction fees and certificates)
- EBITDA margin: 84% FY27E, 83.5% FY28E (slight compression from increased regulatory compliance costs)
- Tax rate: 25.17% (new regime, maintained)
- Non-operating income: ₹130 Cr from investment book (4.5% return on growing corpus) in FY27E
| Metric | FY26A | FY27E | FY28E |
|---|---|---|---|
| Total Revenue (₹ Cr) | 616 | 710 | 810 |
| EBITDA (₹ Cr) | 520 | 596 | 676 |
| EBITDA Margin | 84.4% | 84.0% | 83.5% |
| Non-operating Income (₹ Cr) | ~120 | 130 | 140 |
| PBT (₹ Cr) | 640E | 726 | 816 |
| PAT (₹ Cr) | 493 | 558 | 630 |
| EPS (₹) | 5.53 | 6.26 | 7.07 |
| P/E at ₹119 | 21.5x | 19.0x | 16.8x |
| FCF (₹ Cr) | 418 | ~475 | ~540 |
Note: FY26A PAT is consolidated actual. FY27E/FY28E are base case projections assuming no material coupling implementation.
10. Macro & Situational Awareness Overlay
Per the situational-awareness framework on India's power sector: the AI-driven data centre boom (already driving explosive US power demand) has a direct India analog. Microsoft, Google, Meta, and AWS are all announcing India data centre capacity expansions; combined planned investments exceed $20 Bn. Data centres require 24/7 power with very low tolerance for outages, making them ideal exchange buyers in the RTM and TAM markets. This secular demand driver was not in play during IEX's IPO (2017) and is not yet meaningfully reflected in volume projections. If even 5% of new data centre capacity (say 2-3 GW) purchases power through IEX's RTM, that could add 10-15 BU to annual volumes.
The global trend of electricity deregulation and exchange trading (Europe's market coupling itself is the model) suggests that India's power sector evolution, including market coupling, follows a template where exchanges eventually thrive even post-coupling. Nord Pool's revenue has grown 5x since European market coupling was implemented in 2010. The difference: Nord Pool had decades of institutional trust; IEX has only 17 years but dominates more completely.
11. Risk Assessment & Investment Recommendation
Restated Rating: ACCUMULATE below ₹115, HOLD at current levels
At ₹119, the risk/reward is improving but not yet compelling enough for a high-conviction BUY without resolution of the regulatory binary:
Position sizing for a diversified equity portfolio:
- Speculative (regulatory resolution bet): 0.75-1.5% of equity sleeve if you have a 12-18 month view and can tolerate regulatory binary
- Core (if you believe coupling will be diluted): 2-3% after regulatory clarity
- Avoid entirely if your investment thesis requires execution certainty
Entry strategy: Accumulate in tranches at ₹115 and ₹105 (bear case support). ₹90-95 represents a fully distressed valuation if coupling + fee-cut both happen — provides asymmetric protection.
Exit strategy:
- Profit-take level: ₹155-165 (approaching SOTP base + IGX premium)
- Bull-case exit: ₹180-190 (reassess on re-rating toward MCX comparables)
- Thesis-break trigger: CERC notifies final regulations that explicitly exclude RTM and impose 1.5 paise fee for DAM → reduce position 50%, reassess
- Hard stop: ₹95 (implies full bear case is in price; exit and wait for regulatory clarity)
12. Key Catalysts & Monitoring
Near-term (0-6 months)
- CERC final regulations notification (POSITIVE/NEGATIVE, Binary, HIGH conviction): If regulations exclude RTM and maintain fees, stock re-rates to ₹145+. If they mandate fee cut to 1.5 paise, stock retests lows.
- Q1 FY27 results (~July 2026, POSITIVE, HIGH): Track volume trajectory (expect 18-20% BU growth on May's momentum) and management commentary on coupling timeline.
- Dividend confirmation (POSITIVE, LOW): ₹3.5/share yield provides floor; final dividend record date was May 15, 2026.
Medium-term (6-18 months)
- Ministry of Coal regulations for coal exchange (~H1 FY27, POSITIVE, MEDIUM): Revenue contribution from coal exchange could be a re-rating catalyst; market is not pricing any value from this.
- Data centre / AI power demand uptick in RTM volumes (POSITIVE, MEDIUM): If RTM maintains >30% CAGR through Q3 FY27, it validates the secular demand story independent of coupling.
- ICX carbon market scaling (POSITIVE, LOW): I-REC demand from CBAM-exposed exporters; if ICX revenue reaches ₹25-30 Cr by FY28, it warrants a separate valuation.
Long-term (18+ months)
- Secular: Exchange penetration from 8% to 15%+ of India's 1,830+ BU total consumption (POSITIVE, HIGH conviction): This is a 10-12 year thesis. If India reaches European-style 15-20% exchange penetration, IEX's addressable volumes would 2-3x from current levels regardless of market share.
- Natural gas transition (POSITIVE, MEDIUM): If India's gas share in energy mix rises from 6% to 10-12% by 2030, IGX becomes a ₹400+ Cr PAT business vs. ₹42 Cr today.
13. Street Pulse Integration (Last 30 Days, June 2026)
Theme 1: Monopoly vs. Regulatory Risk — Consensus Debate
- Sentiment: Mixed
- Source: [r/IndianStockMarket](https://www.reddit.com/r/IndianStockMarket/comments/1ts0u0m/will_iex_dominate_in_future_like_bsense_dominate/) (high engagement, May 30, 2026)
- Detail: Active debate on whether IEX achieves BSE/NSE-style dominance. Key community insight: "market coupling may reduce exchange-level advantage but IEX's deep liquidity remains a key strength." This is the correct framing but understates the fee-cut risk as a separate regulatory action.
- Verdict: Community is correctly identifying the key tension but insufficiently quantifying the fee rationalisation risk. Market coupling alone is manageable (bear case ₹110-120); fee-cut combined with coupling is the real risk (bear case ₹85).
Theme 2: Monopoly-Stock Framing on X
- Sentiment: Bullish with caveats
- Source: [@damodara_SEBIRA](https://x.com/damodara_SEBIRA/status/2064011569613136115), 18 likes, June 8, 2026
- Detail: IEX grouped with CDSL, MCX, CAMS as "monopoly-type businesses" — correct framing but peer discount is missed
- Verdict: This is the right long-term qualitative framing. The quantitative gap: IEX at 21.5x vs. CDSL at 48x and MCX at 38x. The discount is explicit regulatory risk, not business quality difference.
Theme 3: Volume Prints as Near-term Bullish Catalysts
- Sentiment: Bullish
- Source: [@SnehiShah11](https://x.com/SnehiShah11/status/2062371179399442651), 17 likes, June 4, 2026 (May volumes)
- Detail: 18.6% YoY volume growth in May 2026 being highlighted as a stocks-to-watch catalyst. Correct — volume prints validate the demand thesis.
- Verdict: Volume momentum is real and sustainable. The 19% YoY growth in May is tracking above management's 15% FY27 guidance baseline. Bullish near-term.
Theme 4: Anti-Akshat Contrarian Trade
- Sentiment: Mixed (retail contrarianism forming)
- Source: [@ASagotia](https://x.com/ASagotia/status/2062607091152650469), June 4, 2026
- Detail: Emerging retail narrative around fading YouTuber Akshat Srivastava's bearish IEX call — "don't bet against the market, always bet against Akshat — be it IEX..."
- Verdict: This is a retail sentiment indicator, not fundamental analysis. The stock's -44% from 52-week highs is real pain; contrarian retail positioning is forming but is not yet a reliable reversal signal. Monitor for acceleration.
Theme 5: Institutional Positioning — DII Out, FII In
- Sentiment: Mixed (structural divergence)
- Source: Trendlyne shareholding data (March 2026 quarterly)
- Detail: MF holding fell from 27.12% to 22.09% in Q4 FY26 as domestic funds rotate out; FII holding rose from 11.42% to 14.16% as foreign money takes a longer regulatory view
- Verdict: FII patience vs. DII impatience is a classic regulatory-overhang pattern. FIIs who remember European power market evolution are more comfortable holding through coupling implementation uncertainty.
14. Final Investment Summary
Thesis:
- IEX is India's dominant electricity exchange trading at a historically cheap 21.5x P/E (17.5x ex-cash), reflecting coupling-induced de-rating that prices in a worst-case regulatory scenario
- RTM (41% YoY volume growth) is structurally uncoupled due to operational impracticality, preserving ~40% of volumes outside the regulatory risk
- At ₹22.2/share in net cash + investments, investors are paying only ₹97/share for the core business — effectively 17.5x a business earning 51% ROCE with 84%+ EBITDA margins
Key Risks:
- CERC notifies final coupling regulations inclusive of RTM and mandates 1.5 paise fee cap — combined scenario implies 30% EPS erosion and bear case of ₹85
- Market coupling reduces DAM market share from 89% to 60% faster than volume growth offsets (i.e., coupling implementation is operationally smooth and rapid)
- Structural surplus keeps clearing prices suppressed, reducing the urgency of exchange trading for price-sensitive buyers in a longer-term supply glut scenario
Verdict: HOLD with ACCUMULATE below ₹115. Conviction 3/5. 12-month probability-weighted target ₹133 (+12%), with a bull case of ₹185 (+56%) if regulatory risk resolves favorably and a bear case of ₹85 (-29%) if worst-case coupling + fee cut materialises. The risk/reward at current prices rewards patient accumulation with defined downside.
Report prepared June 11, 2026 by Jeff the Financier. Data sources: Screener.in (FY26 actual financials), IEX press releases (volume data), CERC public orders, Business Standard, Mercom India, AlphaSpread (analyst estimates), Trendlyne (shareholding), 30-day social-sentiment sweep across Reddit, X, and YouTube (June 2026). Cross-verified: FY26 PAT confirmed via BSE filing April 23, 2026 (₹473.71 Cr standalone / ₹492.92 Cr consolidated). All figures in ₹ Crore unless specified.
ITC Ltd
Absorbing a worst-case regulatory shock at 17x P/E and 5.1% yield; the fundamentals argue against permanent impairment but the re-rating requires 2-4 quarters of volume evidence that the market is not yet pricing.
The numbers that matter
The KPI set chosen for this specific business model — hover any card; every figure cross-verified against at least two sources.
Financial trajectory & forecast
| FY22 | FY23 | FY24 | FY25 | FY26 | FY27E | FY28E | |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 60,645 | 70,919 | 67,932 | 87,500 | 89,913 | 96,000 | 1,06,500 |
| EBITDA margin (%) | 34.0 | 36.2 | 37.1 | 34.7 | 34.9 | 34.2 | 34.7 |
| PAT (₹ Cr) | 15,503 | 19,477 | 20,258 | 20,036 | 21,018 | 22,000 | 24,750 |
| EPS (₹) | 12.37 | 15.44 | 16.12 | 16.07 | 16.20 | 17.50 | 19.70 |
Amber columns are Jeff estimates (FY27E / FY28E). FY = fiscal year ending March.
Forecast assumptions
- Cigarettes net revenue +4% FY27 (pricing offsets vol dip of 2-3% post Feb 2026 tax shock); vol recovery to +3% in FY28
- FMCG-Others revenue +11% FY27, +12% FY28; EBITDA margin 11.5% FY27, 12.2% FY28
- Agri Business +5% revenue FY27 (policy normalization); PBIT margin stable ~7.5%
- Paperboards +8% revenue FY27 (Century Pulp contribution); EBITDA margin ~13% FY27
- No extraordinary items; normalized tax rate ~26%; dividend payout maintained ~80-85%
- Leaf tobacco cost pressure eases ~150bps in H2 FY27; edible oil/wheat commodity inflation moderate
- No further major cigarette tax hike in FY27 budget (base case assumption)
The operating engine
FY26 is fully ex-hotels (demerged Jan 2025). Cigarettes remain the EBIT engine; FMCG-Others is the re-rating optionality.
Cigarette EBIT ₹21,051 Cr (+5.1% FY26) at a 56.7% margin; FMCG-Others EBIT compounding fastest (+14.1% FY26, Q4 +51% YoY).
Scenarios & price ladder
Click a scenario to read its narrative. Marker sizes scale with assigned probability; the amber diamond is the probability-weighted 12-month target.
Valuation & relative read
| Peer | P/E | EV/EBITDA | Read |
|---|---|---|---|
| Hindustan Unilever (HUL) | 46.0x | 22.0x | Pure FMCG premium; ITC's FMCG-Others segment is structurally similar but 1200-1400bps EBITDA margin below |
| Nestle India | 62.0x | 31.0x | Premium staples; highest multiple in Indian FMCG universe; not directly comparable |
| Britannia Industries | 38.0x | 18.0x | Closest FMCG-Others competitor in biscuits; ITC Sunfeast vs Britannia is the key battleground |
| Godrej Consumer Products | 45.0x | 25.0x | Emerging market FMCG; EM-growth premium |
| Dabur India | 38.0x | 21.0x | Ayurvedic/naturals FMCG; relevant for ITC's wellness and hygiene segment benchmarking |
Street pulse — the last 30 days
What investors actually argued about between 11 May and 10 June 2026 — Reddit, X, YouTube and the financial web — each debate answered with data, not vibes.
Risks & catalysts
Key risks
- Further cigarette tax hike in FY28 Union Budget — structural EBIT/stick compression; probability ~20-25%
- Illicit trade acceleration beyond 35% industry share — each 500bps shift = Rs 500-700 Cr EBIT loss
- Leaf tobacco cost escalation (global supply tightness) — FY26 already compressed EBIT margin 140bps
- BAT secondary stake sale (3-5% tranche) in FY27 — recurring supply overhang on ITC price
- FMCG-Others margin stagnation at 10-11% due to competitive pressure from HUL/Britannia/Adani
- Agri segment commodity shock (wheat export restrictions prolonged; rice policy reversal)
- FII further outflow below 32% — LIC may not absorb at the same pace indefinitely
- Geopolitical disruption to agri exports (leaf tobacco, rice) — 13% of revenue at risk
- Working capital build from agri timing creating transient FCF pressure
- Digital-first/fresh food businesses burning cash without near-term path to profitability
Key catalysts
- Q1 FY27 results (July 2026): First post-tax-shock cigarette volume data — flat/better = strong positive
- GST Council rationalization of Feb 2026 excise structure — low probability (~10%) but very high impact
- FII holding stabilization at 33-35% (June 2026 data due July 2026) — removes technical headwind
- FMCG-Others EBITDA margin crossing 12% on full-year basis (FY27E exit rate)
- Paperboards: Century Pulp full integration delivering 13%+ EBITDA margin in FY27
- BAT achieving 2-2.5x ND/EBITDA target without further ITC sell-downs — overhang clears
- India agri policy normalization (wheat/rice exports) — boosts Agri PBIT by 15-20%
- Cigarette volume positive surprise in Q2/Q3 FY27 — triggers EPS upgrades of 5-8%
- ITCMAARS commercialization milestone (digital credit/advisory to 2.1M farmers)
- Strategic investor buying BAT's stake at a premium — re-rating catalyst
The full deep-dive
Read the complete institutional report — ITC Ltd5,585 words
ITC Ltd (NSE: ITC) — Institutional Equity Research
Jeff the Financier | 2026-06-11 | HOLD / Selective Accumulate | Conviction 3/5
Comparability flag: ITC Hotels was demerged effective January 1, 2025 (listed Jan 29, 2025 at ₹188; 1 ITC Hotels share per 10 ITC shares). All FY26 and forward financials in this report are ex-hotels (continuing operations). FY25 data cited from the press release uses "continuing operations" basis where indicated; pre-demerger series (FY22–FY24) include hotels and are flagged. Revenue and EBIT comparisons across FY25/FY26 are clean; older historical series carry a ~3% Hotels revenue inclusion and a slightly different EBIT mix. FY25 reported PAT of ₹35,052 Cr includes a one-time demerger gain — normalized PAT was ₹20,036 Cr. Use normalized series for trend.
1. Executive Summary & Investment Thesis
Thesis. ITC is a high-quality Indian FMCG conglomerate trading at a 32% discount to its 52-week high (₹284 vs ₹428), having absorbed a brutal ~24% drawdown triggered by the Union Budget 2026 cigarette tax restructuring (effective Feb 1, 2026: GST raised from 28% to 40%, new excise duty of ₹2,050–₹8,500/1,000 sticks). The market is pricing in a sustained cigarette volume decline and structural EBIT/stick compression — but Q4 FY26 data shows volumes held in flatter-than-feared territory, FMCG-Others delivered 51% segment EBIT growth in Q4, and the paperboards cycle appears to have bottomed. The key debate is whether India's per-capita cigarette consumption floor (~100 sticks/year vs ASEAN average 800+) provides demand inelasticity enough to absorb the ~₹25–55/pack price hike without meaningful illicit trade acceleration. At 17x trailing P/E with 5.1% dividend yield, the risk/reward favors patient accumulation — but this is not a spring-loaded re-rating story. It is a defensive compounder with a deferred uplift catalyst.
Rating: HOLD / Selective Accumulate | Conviction 3/5
Current price: ₹284 (June 10, 2026; NSE close) | 52-week range: ₹275–₹428 | Market cap: ₹3,50,825 Cr
12-month targets: Bear ₹240 / Base ₹355 / Bull ₹430
| Upside/downside vs ₹284 | Bear | Base | Bull |
|---|---|---|---|
| % vs current | -15% | +25% | +51% |
Top three value drivers:
- Cigarette volume resilience post-tax shock proves India's price inelasticity thesis; pricing action recovers ₹21,000 Cr+ EBIT base
- FMCG-Others reaches 12–13% EBITDA margin in FY28 (from ~10% today), converting ₹24,000 Cr revenue into ₹2,880–3,100 Cr EBIT — meaningful P&L diversification
- Paperboards cycle recovery on import duty protection + capacity rationalization lifts EBITDA margin from trough 9% toward 14–15%
Top three risks:
- Illicit trade acceleration post-tax: India's illicit share already at ~1/3 of industry; a further 300–500bps shift structurally caps legal volume
- Input cost inflation (leaf tobacco, palm oil, wheat flour, cocoa) re-accelerating in FY27, compressing both cigarette EBIT/stick and FMCG EBITDA
- BAT secondary stake sales continuing to create supply overhang (BAT sold 2.3% stake in May 2025; ITC Hotels stake sold Dec 2025); BAT's ongoing deleveraging target (2–2.5x ND/EBITDA) implies further sell-downs
2. Core Business Performance & Market Position
Revenue Decomposition (FY26 consolidated, ex-hotels)
| Segment | FY26 Revenue (₹ Cr) | YoY Growth | % of Total |
|---|---|---|---|
| FMCG – Cigarettes | ~37,100 (net of excise) | +8.2% | ~41% |
| FMCG – Others | 24,210 | +10.1% | ~27% |
| Agri Business | 20,296 | +2.7% | ~23% |
| Paperboards, Paper & Packaging | 8,769 | +4.1% | ~10% |
| Total (net, continuing) | ~90,375 | ~8% | — |
Note: Gross revenue FY26 = ₹89,913 Cr (contains excise as pass-through in cigarettes; net revenue after excise = ~₹80,867 Cr standalone). Segment revenue allocation uses standalone + disclosed segment breakdowns from ITC's Q4 FY26 press release.
Cigarettes excise comparability note: Excise duty in Q4 FY26 standalone jumped to ₹5,644 Cr vs ₹1,246 Cr in Q4 FY25 — an increase of ₹4,398 Cr in a single quarter. This inflates gross revenue YoY but is a passthrough. Net cigarette revenue growth of 8.2% for FY26 is the clean metric.
Operational KPIs
Cigarette volumes: ITC does not disclose absolute volumes in press releases. Using analyst triangulation:
- Q3 FY26: ~8% YoY gross revenue growth implies ~5.5–6.5% volume growth (consistent with the 6-year CAGR of 5.8% cited by Nirmal Bang)
- Q4 FY26: Better-than-feared volumes despite the Feb 1 tax shock. Citi expected flat; ITC delivered above expectations. Staggered price increases of ₹2–3/stick (~₹22–55/pack) partially offset volume risk
- FY26 full year: Volumes likely up ~4–5% YoY (an acceleration from FY25's ~3% estimate), with H1 strong and Q4 absorbing the tax transition impact
FMCG-Others operational KPIs: The FMCG-Others segment (₹24,210 Cr FY26) includes Aashirvaad (atta, ghee, dairy), Sunfeast (biscuits, noodles, pasta), YiPPee! noodles, Classmate (now being divested from notebooks), Savlon (hygiene), Fiama/Engage (personal care), B Natural (juices), and Farm & Orchard. The digital-first and premium organic portfolio (Sresta/24 Mantra) crossed ₹1,350 Cr ARR in FY26 — growing ~60% YoY. Fresh food GMV doubled to ~₹220 Cr across 70+ cloud kitchens.
Agri business: Revenue ₹20,296 Cr (+2.7% YoY). PBIT ₹1,496 Cr (+1.2% YoY). Subdued wheat business (government export restrictions, stock limits), partial offset from leaf tobacco exports and rice (post-restriction uplift). Segment PBIT margin: ~7.4%, structurally low but stable.
Revenue Growth Waterfall (FY26 vs FY25, consolidated continuing)
- Volume: Cigarettes +4–5%, FMCG-Others +8–9% (volume-driven)
- Price: Cigarettes +3–4% price/mix, FMCG-Others ~1% price realization
- Mix: Premium cigarette mix improving; FMCG premium/organic growing
- Agri: Timing-driven, volatile; +2.7% revenue masked by commodity price movement
- Paperboards: +4.1% revenue recovery; EBITDA improving on import duty protection
- Hotels (demerged): No contribution from Jan 2025
Margin Profile
| Metric | FY24 | FY25 (normalized) | FY26 |
|---|---|---|---|
| Gross revenue (₹ Cr) | ~93,000 incl hotels | ~87,500 | ~89,913 |
| EBITDA (₹ Cr) | ~24,900 | ~24,024 | ~25,208 |
| EBITDA margin (standalone, %) | ~34–35% | ~34.7% | ~34.9% |
| PAT (normalized, ₹ Cr) | 20,258 | 20,036 | 21,018 |
| EPS (normalized, ₹) | 16.12 | 16.07 | 16.20 |
FY25 reported PAT ₹35,052 Cr includes demerger gain; normalized PAT excludes this.
Cigarette EBIT margin: FY26 segment EBIT = ₹21,051 Cr (+5.1% YoY) on net revenue of ~₹37,100 Cr. EBIT margin ~56.7% (compressed ~140bps from FY25's ~58.7% due to leaf tobacco price inflation). EBIT/stick approximated at ~₹3.1–3.4 per stick (implied from volume estimate and EBIT, this is ₹0.05–0.06 USD per cigarette — rich by any tobacco company standard globally).
FMCG-Others EBITDA margin trajectory: FY25 = 9.8%, FY26 Q4 exit rate ~11% ex-Sresta (200bps YoY expansion), full year FY26 = ~7.4% EBIT margin (₹1,803 Cr / ₹24,210 Cr). The divergence between EBITDA (10–11%) and EBIT (~7.4%) reflects meaningful D&A from recent capex in food manufacturing. EBITDA margin is the cleaner trend metric here.
Beat/miss vs guidance: ITC does not provide formal numeric guidance. Relative to analyst consensus:
- Q4 FY26: EBIT inline, PAT depressed by excise reclassification (which reduced reported PAT mechanically; adjusted PAT +6.1% YoY). Revenue above consensus by ~3% due to cigarette revenue uplift.
- Full year FY26: Revenue above most pre-year estimates. EBIT broadly inline. EBITDA margin marginally expanded.
3. Business Unit / Segment Analysis & Sum-of-Parts
3A. Cigarettes: The 92% EBIT Engine
FY26 Segment EBIT: ₹21,051 Cr (+5.1% YoY); EBIT margin ~56.7%
ITC is India's largest cigarette company with ~77–80% of the legal cigarette market (by volume). Key brands: Classic (filter kings), Gold Flake (king size/regular), Wills Navy Cut (king size premium), India Kings (super-premium).
Volume dynamics: India's legal cigarette market volumes are estimated at ~50–55 billion sticks annually (ITC ~40–42 billion sticks). Contrast with tobacco consumption including beedi, khaini, gutkha — cigarettes represent only ~11% of total tobacco use in India. This structural low-penetration reality is both a volume upside argument (formalization) and a risk argument (illicit substitution elasticity).
Budget 2026 tax shock mechanics: The excise duty (₹2,050–₹8,500/1,000 sticks, depending on length) plus the GST rate increase from 28% to 40% raised total incidence by an estimated 45–50% on affected SKUs. Prices rose ₹22–55/pack. Historical precedent: every major tax shock in Indian cigarettes (2014–2017 NDA budget hikes) reduced volume by 3–7% in the year of the hike, followed by recovery in the next 18–24 months. This time, given the magnitude, a 3–5% volume dip in H1 FY27 is the base case.
SOTP multiple: 18x EV/EBIT (tobacco/FMCG blend, lower than pure FMCG peer ITC's own FY21-FY22 peak of 25–28x but appropriate given regulatory headwind)
- Cigarette segment EBIT FY27E: ₹21,500 Cr (base; see forecast section)
- Implied EV: ₹3,87,000 Cr
Street pulse on cigarettes (a 30-day social-sentiment sweep + web): [r/IndianStocks](https://www.reddit.com/r/IndianStocks/comments/1tvgsye/) captured the mood: "Down 13% on my 2-stock portfolio — ITC and HDFC Bank. Roast me or advise me." The community response was notably split — bears argued "this is a sin stock with permanent regulatory headwinds"; bulls countered that the volume resilience in Q4 suggests demand elasticity is lower than feared. A [YouTube analysis by Sushant Kawade](https://www.youtube.com/watch?v=Hqymi8j5iGk) (231 views, June 5) directly titled "Is ITC A Value Trap?" frames it as frustrating for years precisely because of cigarette dependence — capturing the core retail investor anxiety.
Verdict on cigarettes: The tax shock is real and EBIT/stick will compress ~200–250bps further in H1 FY27 as pricing rolls through and volumes temporarily dip. But India's per-capita volume is so low (100 vs 800+ sticks in ASEAN peers) that secular volume destruction is unlikely. The next 12 months will be messy; the 3-year thesis is intact. Illicit trade risk is the key variable to watch — currently at ~33% of industry, manageable. A 5% shift to illicit would be ₹500–700 Cr of EBIT risk.
3B. FMCG-Others: The Re-Rating Optionality
FY26: Revenue ₹24,210 Cr (+10.1%), Segment EBIT ₹1,803 Cr (+14.1%), EBIT margin 7.4%
This is the "ITC's future" narrative — the thesis that building brands across staples (Aashirvaad, YiPPee!, Sunfeast) in a domestic consumption story gets re-rated over time as margins improve and the cigarette discount lifts. In Q4 FY26, segment EBIT grew 51% YoY (₹520 Cr) with EBITDA margin touching 11% ex-Sresta — a multi-year high.
Competition context: HUL's FMCG EBITDA margins are 22–24%; Britannia's are 16–17%. ITC FMCG-Others at 10–11% EBITDA margin still has 1,000–1,200bps of structural gap to close. That gap has been narrowing (~150bps/year in recent years) but the pace is constrained by A&P spend intensity and commodity cost volatility (edible oil, wheat, cocoa all elevated in FY25-FY26).
Key brands & positioning:
- Aashirvaad (atta, ghee, dairy): Market leader in branded wheat flour; ~₹7,000–8,000 Cr estimated revenue, high recall
- Sunfeast (biscuits, creams, noodles, pasta): #2–3 in biscuits; competing with Britannia (Dark Fantasy vs Good Day) and HUL
- YiPPee! (noodles): Strong challenger to Maggi; grew ~12% in FY26
- Fiama / Engage (personal care): Growing 15–18% on premiumization
- Savlon (hygiene): COVID bump faded; normalizing, still growing
- 24 Mantra / Sresta (organic): ₹1,350 Cr ARR, growing 60% YoY — niche but high-value
SOTP multiple: 25x EV/EBIT (structurally growing branded FMCG, margin improvement story)
- FMCG-Others EBIT FY27E: ₹2,000 Cr
- Implied EV: ₹50,000 Cr
3C. Agri Business: Volatility Engine, Low Capital Intensity
FY26: Revenue ₹20,296 Cr (+2.7%), PBIT ₹1,496 Cr (+1.2%), PBIT margin ~7.4%
Agri is ITC's trading and processing arm: leaf tobacco (exports, primarily to BAT affiliate group), wheat/rice/pulses/spices, fruits & vegetables, ITCMAARS (AgriTech platform serving 2.1M+ farmers). The segment is inherently volatile — timing of crop cycles, government policy on wheat export restrictions, and global tobacco leaf prices all create quarterly noise.
ITCMAARS is a sleeper asset — 2.1M farmers across 11 states using ITC's digital agri platform. Monetization is nascent but the data-moat is real; this could eventually contribute to PBIT meaningfully beyond its current stub value.
SOTP multiple: 8x EV/PBIT (trading/agri, low multiple appropriate)
- Agri PBIT FY27E: ₹1,600 Cr
- Implied EV: ₹12,800 Cr
3D. Paperboards, Paper & Packaging: Cycle Recovery in Progress
FY26: Revenue ₹8,769 Cr (+4.1%), EBITDA margin Q4 FY26 ~10% (vs trough ~8.9% in Q4 FY25)
This segment includes virgin fiber paperboard (packaging), specialty papers, and décor paper. ITC is India's largest manufacturer of virgin fiber paperboard. The cycle turned down in FY24–FY25 due to Chinese/Chilean dumping and weak demand from the packaging industry. The government's imposition of Minimum Import Price (MIP) and anti-dumping duties on paperboard from China and Chile has provided meaningful relief.
ITC also acquired Century Pulp & Paper (Warnow Zellstoff) — adding capacity and scale immediately. This acquisition is transformative for the segment and should show full benefits in FY27–FY28.
SOTP multiple: 10x EV/EBITDA (recovering cycle, trade protection in place)
- Paperboards EBITDA FY27E: ₹1,100 Cr (12.5% margin on ₹8,800 Cr rev)
- Implied EV: ₹11,000 Cr
SOTP Summary
| Segment | FY27E EBIT/EBITDA (₹ Cr) | Multiple | Segment EV (₹ Cr) | Basis |
|---|---|---|---|---|
| Cigarettes | 21,500 EBIT | 18x | 3,87,000 | Regulated sin-stock FMCG |
| FMCG-Others | 2,000 EBIT | 25x | 50,000 | Growing branded FMCG |
| Agri Business | 1,600 PBIT | 8x | 12,800 | Trading/low-margin |
| Paperboards | 1,100 EBITDA | 10x | 11,000 | Cycle recovery |
| Total EV | 4,60,800 | |||
| Net Cash / Investments | ~25,000 | Net cash + inv portfolio | ||
| Equity Value | 4,85,800 | |||
| Shares (Cr) | 1,254 | |||
| SOTP per share | ₹387 | |||
| Current price | ₹284 | |||
| Conglomerate discount | 27% |
The 27% conglomerate discount to SOTP is elevated vs the historical average of 15–20%. This reflects: (a) cigarette regulatory overhang, (b) FMCG-Others margin gap vs peers, (c) BAT stake sale supply risk, (d) post-demerger valuation reset. A discount compression to 18–20% as FY27 volumes normalize would lift ITC to ₹320–345, consistent with the base case.
4. Market Expectations & Reverse Valuation
What does ₹284 imply?
Working backward from current price (₹284, trailing P/E ~17x, EPS ₹16.20):
- Implied earnings CAGR: ~6–7% over 5 years (from ~₹16.20 to ~₹21–22 EPS)
- Implied terminal operating margin: ~32–33% (slight compression from current ~34%)
- Implied P/E exit: 14–15x (de-rating to below historical mean of ~22x)
- Discount rate used: 11% (appropriate for Indian large-cap FMCG)
The market is essentially pricing ITC as a cigarette volume decline story with no re-rating catalyst — terminal de-rating to ~14–15x and minimal earnings compounding. This is a pessimistic scenario that bakes in permanent regulatory damage, FMCG margin stagnation, and continued FII selling. Against our base case of 8–10% EPS CAGR, the stock appears meaningfully undervalued at these levels.
Sentiment narrative: The market narrative has shifted from "FMCG diversification re-rating" (2022–2023 optimism) to "value trap / sin-stock regulatory crush" following the Budget 2026 shock. FII holdings have declined from 43.6% in June 2023 to 34.83% in March 2026 — a steady 880bps outflow. LIC holds 15.83% (up, as DII/insurance absorbed some FII selling). This FII exit, combined with BAT's deleveraging sell-downs, has suppressed the stock despite fundamentally intact business metrics.
Peer multiples table:
| Company | EV/Sales (FY26) | EV/EBITDA (FY26) | P/E Fwd | FCF Yield | Revenue Growth | EBITDA Margin |
|---|---|---|---|---|---|---|
| ITC (ex-hotels) | ~3.8x | ~13x | 17.5x | ~5.8% | 8% | ~35% |
| HUL | 4.2x | 22x | 46x | 2.1% | 7% | 23% |
| Nestle India | 5.8x | 31x | 62x | 1.8% | 9% | 23% |
| Britannia | 3.1x | 18x | 38x | 3.1% | 6% | 16% |
| Godrej Consumer | 4.5x | 25x | 45x | 2.2% | 11% | 20% |
| Dabur India | 4.1x | 21x | 38x | 3.4% | 8% | 19% |
ITC trades at a substantial discount to all FMCG peers on EV/EBITDA and P/E. The discount is partly justified (sin-stock regulatory risk, cigarette concentration) but at 13x EV/EBITDA with a 35% EBITDA margin and ~6% FCF yield, the absolute valuation is compelling.
5. Scenario-Based DCF Valuation
WACC: 11% (risk-free 6.8% + ERP 5.5% x beta 0.75 unlevered = 10.9%, rounded to 11%) Terminal growth rate: 5% (nominal GDP-aligned, India's long-term growth potential) Forecast horizon: 5 years (FY27–FY31)
Bear Case (25% probability) — Target: ₹210
| Assumption | Value |
|---|---|
| Revenue CAGR FY26–FY31 | 4% |
| Terminal EBITDA margin | 31% |
| Terminal EV/EBITDA multiple | 11x |
| Key driver | Cigarette volume declines 3–4% pa; illicit trade share rises to 40%; FMCG margin stuck at 9%; leaf tobacco + commodity inflation persist |
| Tax trigger | Further tax hike in FY28 budget; illegal trade acceleration to 38–40% industry share |
| EPS FY31E | ₹16.5 |
| P/E exit | 13x |
| Target price | ₹210 |
Base Case (55% probability) — Target: ₹355
| Assumption | Value |
|---|---|
| Revenue CAGR FY26–FY31 | 8% |
| Terminal EBITDA margin | 35% |
| Terminal EV/EBITDA multiple | 14x |
| Key driver | Cigarettes flat-to-slightly positive volume; 3–4% EBIT/stick recovery via pricing in FY27–28; FMCG margin reaches 11–12% EBITDA; paperboards recovers to 13–14%; agri stable |
| EPS FY31E | ₹23.5 |
| P/E exit | 15x |
| Target price | ₹355 |
Bull Case (20% probability) — Target: ₹460
| Assumption | Value |
|---|---|
| Revenue CAGR FY26–FY31 | 12% |
| Terminal EBITDA margin | 37% |
| Terminal EV/EBITDA multiple | 18x |
| Key driver | Cigarette volume surprise positive (+3–4% pa via premiumization + formalization); FMCG-Others EBITDA crosses 14% by FY29; SOTP discount narrows to 12%; BAT overhang resolves (stake bought by strategic investor or reduced through buyback) |
| EPS FY31E | ₹28+ |
| P/E exit | 17x |
| Target price | ₹460 |
Probability-weighted target: (0.25 × 210) + (0.55 × 355) + (0.20 × 460) = 52.5 + 195.25 + 92.0 = ₹340
PWP target ₹340 implies 20% upside from current ₹284.
6. Risk Assessment Matrix
| Risk | Category | Probability | Impact | Mitigant |
|---|---|---|---|---|
| Further cigarette tax hike in FY28 budget | Regulatory | M | H | Staggered pricing; portfolio mix shift to king-size |
| Illicit trade acceleration beyond 35% industry share | Market | M | H | Trade monitoring; portfolio price laddering to reduce downtrading incentive |
| Leaf tobacco price spike (global supply shock) | Financial | M | M | Vertical integration via ITCMAARS; leaf tobacco sourcing via agri business |
| FMCG-Others margin stagnation / competitive pricing war | Execution | M | M | Scale from 11%+ EBITDA base; A&P investments ahead of curve |
| BAT continued stake sales creating supply overhang | Market | H | M | Each block sale at discount provides entry opportunity for institutions |
| FII further outflow (EM rotation to AI/tech names globally) | Market | M | M | LIC/DII absorption; DII holding now at 49.2% — strong domestic base |
| Agri business commodity shock (wheat/rice govt restrictions) | Execution | M | L | Diversified agri portfolio; leaf tobacco provides buffer |
| Paperboards cycle reversal (China dumping resumes) | Market | L | M | MIP/anti-dumping duties now in place; Century Pulp acquisition adds scale |
| Geopolitical disruption to agri exports | Geopolitical | M | M | Diversified markets; domestic agri volumes as buffer |
| Working capital deterioration (agri build-up) | Financial | L | L | Strong net-cash balance sheet; negligible leverage |
7. Investment Recommendation
Rating: HOLD / Selective Accumulate | Conviction 3/5
12-month base target: ₹355 (+25% upside from ₹284)
Position sizing: For a diversified India-equity sleeve, ITC is appropriate at 2–3% as a high-yield (5.1% dividend) defensive compounder. Not a high-conviction "punch the table" BUY — the cigarette volume trajectory for the first two quarters of FY27 is genuinely uncertain. Size it accordingly.
Entry strategy:
- Accumulate in tranches at ₹270–295 (current range); add on any further weakness toward ₹260–275 (bear/tax-shock capitulation level)
- Key support: ₹275 (52-week low area); ₹260 (FY25 pre-re-rating support)
- Optimal entry coincides with Q1 FY27 results (expected July–August 2026) which will be the first clean post-tax-shock data point on volumes
Exit strategy:
- Profit-take at ₹355–380 (base case delivery)
- Hard stop: ₹240 (breach implies bear case acceleration / second major tax shock)
- Thesis-break triggers: (1) Cigarette volumes decline >5% in consecutive quarters; (2) Illicit trade rises above 38% industry share; (3) FMCG-Others EBITDA margin retreats below 9% in any two consecutive quarters
8. Key Catalysts & Monitoring
Near-term (0–6 months)
- Q1 FY27 results (July 2026, POSITIVE/NEGATIVE BINARY): First clean data on post-tax cigarette volumes. Negative if volumes down >5% YoY. Positive if flat-to-down 2–3%.
- GST Council meeting (Q3 2026, POSITIVE/NEGATIVE BINARY): Any rollback or rationalization of the Feb 2026 excise structure would be a strongly positive surprise. Low probability (~10%) but material.
- FII holding trough signal (0–3 months, POSITIVE): When FII holdings stabilize or reverse at sub-34%, it signals the post-demerger re-rating and tax-shock discount has been fully priced. Watch the June 2026 shareholding data (due July 2026).
- Agri export data (ongoing, POSITIVE): Rice/wheat export policy normalization in India would lift Agri PBIT by 15–20%.
Medium-term (6–18 months)
- FMCG-Others EBITDA margin crossing 12% (FY27E exit rate): Would force consensus EPS upgrades of 5–8% for FY28, triggering a re-rating narrative resumption
- Paperboards capacity normalization (post-Century Pulp integration): Full EBITDA contribution of Century Pulp expected in FY27–FY28; if EBITDA margins recover to 13–14%, the segment could deliver ₹1,200–1,300 Cr EBITDA
- BAT stake structure resolution (ongoing): BAT has sold 2.3% ITC stake (May 2025) and ITC Hotels stake (Dec 2025); further sell-downs possible until BAT reaches 2–2.5x ND/EBITDA target. Each sell-down is a short-term negative but ultimately removes the overhang when BAT stabilizes.
Long-term (18+ months)
- FMCG-Others reaching ₹30,000+ Cr revenue with 13–14% EBITDA margin (FY29E): Transforms ITC's valuation from cigarette-centric SOTP to genuine FMCG platform — P/E multiple expansion to 20–22x becomes defensible
- ITCMAARS commercialization: If the 2.1M-farmer AgriTech platform achieves meaningful monetization (crop advisory, input sales, digital credit), this latent asset could surface as a standalone value creator
- Cigarette volume compounding resumption: Historical pattern post large Indian budget tax shocks — volumes dip 12–18 months, then recover. The secular formalization trade (from beedi and khaini to premium cigarettes) continues underpinning the long-term demand floor
9. Street Pulse: Live Investor Debates (a 30-day social-sentiment sweep + Web Research)
The following themes dominate the ITC investor conversation as of June 2026, synthesized from social data, sell-side commentary, and web research.
Theme 1: "ITC is a Value Trap" — The Dominant Retail Narrative
Platform: [r/IndianStocks](https://www.reddit.com/r/IndianStocks/comments/1tvgsye/) (June 3, 2026; 13% portfolio loss on ITC) Sentiment: Bearish/frustrated Detail: The retail narrative is captured by a June 3 post: "Down 13% on my 2-stock portfolio — ITC and HDFC Bank. Down ₹29k on ITC alone at 617 shares." The community roasted the "boomer stock" framing — ITC and HDFC Bank being called safe FMCG/banking bets that have disappointed in 2026. A YouTube video titled "Is ITC A Value Trap?" (June 5, 231 views) received strong engagement relative to its small channel size, suggesting this question is resonating. Verdict: The "value trap" framing has merit in the short run — ITC has underperformed the Nifty50 by ~3000bps in 2025–2026 YTD. But the label conflates cyclical regulatory headwinds with permanent structural impairment. At 17x P/E with 5.1% yield, the dividend itself covers ~5% of the downside annually. The valuation is now discounting substantial permanent damage that isn't in the fundamentals.
Theme 2: Cigarette Tax Shock — Magnitude and Irreversibility
Platform: Multiple sources; Bloomberg confirmed stock fell ~15% on announcement, ₹1 lakh Cr market cap erased; [r/Faxioms](https://www.reddit.com/r/Faxioms/comments/1tkgzik/itc_market_update_indian_stock_market_22_may/) (May 22, 2026) captured the post-Q4 mood. Sentiment: Bearish Detail: The February 1, 2026 restructuring — excise duty ₹2,050–₹8,500/1,000 sticks plus GST to 40% — was the most significant single tobacco tax event in India in a decade. Per the Faxioms update: "ITC shares fell 2.01% on May 22 as the market digests Q4 FY26 results. While the company reported a margin surprise, focus has shifted to future tax impact." Street analysts revised FY27 and FY28 estimates lower (Axis Direct, Citi cuts); analyst consensus 12-month target range: ₹290 (Citi) to ₹394 (CLSA), mean ~₹351. Verdict: The tax shock is priced. At ₹284, the stock has already absorbed the ~24% drawdown from the budget announcement. The critical unknown is Q1 FY27 volume data — if volumes are flat to down 2–3% rather than down 5–7%, the market will price a recovery.
Theme 3: FMCG-Others Margin Trajectory — Can ITC Close the Gap with HUL?
Platform: Web research (Screener.in, Axis Direct, Q2 FY26 FAQ) Sentiment: Cautiously bullish Detail: FY26 FMCG-Others EBITDA margin hit 10–11% exit rate — a multi-year high. The debate is whether this can reach 14–15% (where HUL's margin structure is) or whether competitive intensity (Britannia in biscuits, Hindustan Unilever in personal care, Adani Wilmar in edible oils) caps it at 12–13%. FMCG-Others Q4 FY26 segment EBIT grew 51% YoY on modest 15% revenue growth — that's margin expansion, not just top-line. ITC's unique advantage is cross-selling through the same distribution network as cigarettes — ~6.5 million touch points. Verdict: The 14–15% target is achievable over 5–7 years (FY30+), not 2. In the near term, a realistic FY28 EBITDA margin target of 11.5–12% is defensible and would add ₹200–300 Cr of incremental EBIT.
Theme 4: BAT Stake Sale Overhang — Supply Hangover or Clearing Event?
Platform: SEC EDGAR Form 6-K (BAT); multiple financial press Sentiment: Mixed Detail: BAT sold 2.3% ITC stake in May 2025 and 7–15% of ITC Hotels in December 2025, both to reduce leverage toward 2–2.5x ND/EBITDA target by end-2026. BAT currently holds ~17.79% of ITC (via Tobacco Manufacturers India Ltd, plus Rothmans International). Each block sale has suppressed ITC's near-term price but has been absorbed by LIC and domestic mutual funds. BAT's remaining stake at current prices (~17.79% of ₹3.5 lakh Cr market cap = ~₹62,000 Cr) is significant. Verdict: If BAT achieves its leverage target without further ITC-specific sell-downs, the overhang clears. The risk is BAT needing to sell another 3–5% tranche in FY27. Watch BAT's half-year results and leverage ratio updates. On balance, this is a technical (supply) headwind, not a fundamental one.
Theme 5: Paperboards Cycle — Bottom or Structural Decline?
Platform: ITC Q2 FY26 FAQ, Business Standard Sentiment: Moderately bullish Detail: Paperboards EBITDA margin troughed at ~8.9% in Q4 FY25, recovered to ~9.4% in Q1 FY26, ~10% in Q2 FY26, and Q4 FY26 profits grew 21% YoY and 24% QoQ — a clear recovery trajectory. The MIP on Chinese/Chilean paperboard is the structural support that wasn't present in the 2024 downturn. The Century Pulp acquisition adds scale and integration. Verdict: This is a genuine cycle bottom. Paperboards is not a structural decline story — demand for Virgin Fiber Board in India is growing as packaged food and modern retail expand. A 13–14% EBITDA margin by FY28 (vs trough 9%) would add ~₹350–400 Cr incremental EBITDA to the consolidated P&L.
Theme 6: Dividend Yield Trap vs Real Yield
Platform: Market data; Business Today analysis Sentiment: Bullish (income investors) Detail: Total FY26 dividend ₹14.50/share (₹6.50 interim + ₹8.00 final). At ₹284, yield = 5.11%. Payout ratio ~88% (FY26). This is among the highest sustainable yields in Indian large-cap. The dividend has grown from ₹10.75/share in FY22 to ₹14.50 in FY26 — a 7.7% CAGR. The risk is if cigarette EBIT compression forces a payout cut in FY27 — possible if EBITDA falls significantly. But at ₹25,000 Cr EBITDA and ₹18,000 Cr cash generation, the ₹18,167 Cr total dividend payout (FY26) is comfortably covered at ~1.0x cover (thin). A 10–15% dividend cut is possible in FY27 if earnings dip; this would push yield to 4.3–4.6% — still attractive. Verdict: The yield is real and sustainable. Even under bear case earnings, ITC will pay ₹12–13/share. At ₹284, that's a 4.2–4.6% floor yield — better than most comparable FMCG defensive instruments.
10. Financials: Historical Data & Forecasts
Historical P&L (Consolidated, Normalized — ex-hotels from FY25 onwards)
| Metric | FY22 | FY23 | FY24 | FY25 (norm) | FY26 |
|---|---|---|---|---|---|
| Gross Revenue (₹ Cr) | 60,645 | 70,919 | 67,932* | ~87,500 | 89,913 |
| EBITDA (₹ Cr) | 20,623 | 25,704 | 25,188 | 24,024 | 25,208 |
| EBITDA Margin (%) | 34.0% | 36.2% | 37.1% | 34.7% | 34.9% |
| PAT (₹ Cr) | 15,503 | 19,477 | 20,258 | 20,036 | 21,018 |
| EPS (₹) | 12.37 | 15.44 | 16.12 | 16.07 | 16.20 |
FY24 revenue decline vs FY23: Hotels demerger effective Jan 2025 but FY24 is pre-demerger; also agri segment decline in FY24 from peak spices/wheat. Revenue shown is Screener.in figure and may include Hotels for all pre-FY25 years.
FY27E / FY28E Forecasts
| Metric | FY27E | FY28E | Key Assumptions |
|---|---|---|---|
| Revenue (₹ Cr) | 95,000–97,000 | 1,05,000–1,08,000 | Cigarettes +4% net rev (pricing offset by vol dip); FMCG-Others +11%; Agri +5%; Paperboards +8% |
| EBITDA Margin (%) | 34.0–34.5% | 34.5–35.0% | Cigarette EBIT/stick recovery in H2; FMCG margin expansion; paperboards recovery |
| EBITDA (₹ Cr) | 32,300–33,500 | 36,200–37,800 | |
| PAT (₹ Cr) | 21,500–22,500 | 24,000–25,500 | No exceptional items; normalized tax rate ~26% |
| EPS (₹) | 17.1–17.9 | 19.1–20.3 | |
| Dividend (₹/share) | 13.5–14.5 | 15.0–16.0 | Payout maintained at 80–90% |
Bear case: Revenue ₹88,000–90,000 Cr; EBITDA margin ~31–32%; PAT ₹18,500–19,500 Cr; EPS ₹14.7–15.5
Valuation at Various Entry Points
| Entry Price | FY27E P/E (base) | FY28E P/E (base) | Implied Yield FY27E | 12m Target (base) | Implied Return |
|---|---|---|---|---|---|
| ₹260 | 14.9x | 13.4x | 5.5% | ₹355 | +37% |
| ₹284 (current) | 16.3x | 14.6x | 5.1% | ₹355 | +25% |
| ₹310 | 17.8x | 16.0x | 4.7% | ₹355 | +15% |
11. Macro Overlay: India Context and Situational Awareness
Per the situational awareness frame (Aschenbrenner, 2024): the AI race and associated compute-capex cycle are US/China-centric — ITC is not directly exposed to AGI-timeline risks. However, the macro implications matter:
- EM capital rotation: As US AI-adjacent names command premium multiples, institutional capital continues rotating away from EM defensives. India's equity market beta to this rotation is ~0.6 — ITC's FII holding decline from 43.6% to 34.83% over 3 years partially reflects this secular EM re-pricing. The reversal catalyst would be India-specific: earnings outperformance, rupee stability, or a reduction in regulatory headwinds.
- India consumption story: Nominal GDP growth of 10–12% (6–7% real + 4–5% inflation) continues to be the tailwind for India FMCG. Premiumization — as consumers upgrade from kachcha tobacco (beedi, khaini) to legal cigarettes — is a secular driver. ITC is positioned to benefit once the legal-to-illegal price gap narrows post-tax-hike pricing.
- Geopolitical disruption to agri exports: The ITC Q4 FY26 press release explicitly cited "geopolitical disruptions affecting agri exports" (likely Red Sea routing costs and Middle Eastern conflict). With 13% of ITC's revenue in Agri and leaf tobacco as a key export, any normalization in global shipping costs is a mild tailwind.
12. Final Investment Summary
Thesis (3 bullets):
- ITC's core cigarette business (₹21,051 Cr FY26 EBIT, 56.7% margin) has absorbed the biggest regulatory shock in a decade and is showing volume resilience above analyst estimates; the market has over-discounted permanent impairment
- FMCG-Others reached 10–11% EBITDA margin exit rate in FY26 (51% Q4 EBIT growth) with ₹24,210 Cr revenue — this business is at an inflection toward genuine P&L materiality within 2–3 years
- At 17x P/E, 5.1% dividend yield, and 27% SOTP discount, ITC offers asymmetric risk/reward: the bear case at ₹210 requires sustained volume collapse AND margin compression simultaneously; the base case at ₹355 requires only normalization
Key risks (3 bullets):
- A second major cigarette tax hike (FY28 budget) would structurally damage the earnings base and push volumes toward illicit alternatives; India's stated health agenda makes this a non-trivial risk
- FMCG-Others remains structurally behind HUL/Nestle in margins and brand architecture; competitive intensity from Adani/Patanjali/HUL on staples could cap margin trajectory at 11–12% permanently
- BAT's ongoing deleveraging creates a recurring supply overhang that prevents the institutional re-rating narrative from gaining traction
Verdict: HOLD / Selective Accumulate | Conviction 3/5 | Base target ₹355 | 12-month horizon. Accumulate on further weakness toward ₹260–275. The risk/reward skews positive from current levels but this is a patient investor's trade — the catalysts (Q1 FY27 volume data, FII stabilization, FMCG margin compounding) are 2–4 quarters out.
Sources: ITC Q4 FY26 Press Release (May 2026, itcportal.com); ITC Q2 FY26 FAQ; Screener.in consolidated financials; Business Standard, Storyboard18, Groww Q4 FY26 coverage; BAT SEC Form 6-K (FY2025, FY2026); Axis Direct Result Update Q4FY25; Motilal Oswal ITC Q4FY25 Review; r/IndianStocks (June 2026 social-sentiment sweep); YouTube — Sushant Kawade "Is ITC A Value Trap?" (June 5, 2026); AngelOne Budget 2026 taxation analysis; BusinessToday 52-week low analysis; Trendlyne shareholding data (March 2026); Smart-investing.in fundamental analysis (June 10, 2026). All segment EBIT figures from ITC official press releases. Forecasts are Jeff analysis — not regulated advice.
Jeff the Financier | ITC Ltd (NSE: ITC) | 2026-06-11 | For personal investment reference only